Mask system with snap-fit shroud

Abstract
A shroud for a mask system includes a retaining portion structured to retain a frame, a pair of upper headgear connectors each including an elongated arm and a slot at the free end of the arm adapted to receive a headgear strap, and a pair of lower headgear connectors each adapted to attach to a headgear strap. The retaining portion, the upper headgear connectors, and the lower headgear connectors are integrally formed as a one piece structure.
Description
FIELD OF THE INVENTION

The present invention relates to a mask system used for treatment, e.g., of Sleep Disordered Breathing (SDB) with Continuous Positive Airway Pressure (CPAP) or Non-Invasive Positive Pressure Ventilation (NIPPY).


BACKGROUND OF THE INVENTION

Patient interfaces, such as a full-face or nasal mask systems, for use with blowers and flow generators in the treatment of sleep disordered breathing (SDB), typically include a soft face-contacting portion, such as a cushion, and a rigid or semi-rigid shell or frame. In use, the interface is held in a sealing position by headgear so as to enable a supply of air at positive pressure (e.g., 2-30 cm H2O) to be delivered to the patient's airways.


One factor in the efficacy of therapy and compliance of patients with therapy is the comfort and fit of the patient interface.


The present invention provides alternative arrangements of mask systems to enhance the efficacy of therapy and compliance of patients with therapy.


SUMMARY OF THE INVENTION

One aspect of the invention relates to a mask system provided without a forehead support adapted to engage the patient's forehead.


Another aspect of the invention relates to a mask system including a frame and a shroud removably connected to the frame and adapted to attach headgear.


Another aspect of the invention relates to a mask system including a frame defining a breathing chamber, a cushion provided to the frame and adapted to form a seal with the patient's face, and a shroud provided to the frame. The shroud and the frame are co-molded with one another. The frame is constructed of a first, relatively soft, elastomeric material and the shroud is constructed of a second material that is more rigid than the frame. At least a portion of the frame includes a concertina section having a plurality of folds. Each of the folds has a side wall with the side walls of the folds becoming progressively longer away from the patient's face.


Another aspect of the invention relates to a cushion module including a frame defining a breathing chamber and a cushion adapted to form a seal with the patient's face. The frame and the cushion are co-molded with one another. The cushion is constructed of a first, relatively soft, elastomeric material and the frame is constructed of a second material that is more rigid than the cushion. At least a portion of the frame includes a concertina section.


Another aspect of the invention relates to a method for constructing a cushion module. The method includes molding a first part of the cushion module with a first, relatively soft, elastomeric material, co-molding a second part of the cushion module to the first part with a second material that is more rigid than the first material, and molding at least a portion of the second part to include a concertina section.


Another aspect of the invention relates to a shroud for a mask system including a retaining portion structured to retain a frame, a pair of upper headgear connectors each including an elongated arm and a slot at the free end of the arm adapted to receive a headgear strap, and a pair of lower headgear connectors each adapted to attach to a headgear strap, wherein the retaining portion, the upper headgear connectors, and the lower headgear connectors are integrally formed as a one piece structure.


Another aspect of the invention relates to a mask system including a frame defining a breathing chamber, a cushion provided to the frame and adapted to form a seal with the patient's face, a shroud provided to the frame and adapted to attach headgear, and an elbow provided to the frame and adapted to be connected to an air delivery tube that delivers breathable gas to the patient. The shroud includes a retaining mechanism structured to establish a positive connection between the shroud and the frame.


Another aspect of the invention relates to a mask system including a frame defining a breathing chamber and a cushion provided to the frame. The cushion includes a main body and a cushion, wherein the cushion is adapted to engage at least a portion of the patient's face. The cushion includes a base wall connected to an undercushion layer and a membrane, wherein the membrane extends around the perimeter of the cushion and contacts the patient's face. The undercushion layer is positioned underneath the membrane and supports the membrane. The under cushion layer provides differential support to the membrane at predetermined regions of the face.


Another aspect of the invention relates to a mask assembly for use in medical applications having a top and bottom ends defined by its position relative to a patient's face, wherein the mask assembly is connected to a plurality of flexible straps, which are adapted to engage the patient's head. The flexible straps engage at least two elongated rigid arms integrally molded to a portion of the mask assembly, and wherein the elongated arms are molded to the mask assembly proximal to the top end of the mask assembly.


Another aspect of the invention relates to a mask assembly for use in medical applications including a main body connected to a cushion adapted to cover nose and/or mouth and wherein the mask assembly is attached by a force substantially perpendicular towards the face and wherein the force is approximately constant along the length of the mask and is balanced by a portion of the cushion engaging the patient's cheeks.


Another aspect of the invention relates to a cushion for use with a medical mask including an outer membrane layer adapted to sealably engage a face and an undercushion layer adapted to support the membrane layer. The membrane or undercushion layer includes a surface positioned between the two layers adapted to allow the layers to slide against the respective surface.


Another aspect of the invention relates to a mask system including a frame defining a breathing chamber, a cushion provided to the frame and adapted to form a seal with the patient's face, and a releasable shroud adapted to engage a portion of the outer surface of the frame, wherein the shroud is connected to straps to position the mask system.


Another aspect of the invention relates to a mask assembly for use in medical applications including an upper end and a lower end wherein the upper end is adapted to cover the nose and the lower end is adapted to cover the mouth of a patient. The mask assembly includes no forehead support and includes two stiffened members attached to the upper end on opposed sides of the mask assembly, and wherein the stiffened members include a general curved shape and adapted to avoid covering the patient's field of vision.


Another aspect of the invention relates to a cushion for attaching to a medical mask, wherein the cushion is flexible and includes a membrane attached to the circumference of the cushion adapted to seal against the face of a patient, and at least one undercushion adapted to support the membrane and positioned underneath the membrane to prevent collapse of the membrane, in use. The membrane is softer than the undercushion. The undercushion in the regions of nasal bridge or chin is between 0 mm and 30 mm in height as measured between the base and the tip of the undercushion.


Another aspect of the invention relates to a mask assembly for use in medical applications including an upper end and a lower end wherein the upper end is adapted to cover the nose and the lower end is adapted to cover the mouth of a patient. The mask assembly includes no forehead support and includes two stiffened members attached to the upper end on opposed sides of the mask assembly, and wherein the stiffened members include a general curved shape and adapted to avoid covering the patient's field of vision.


In an alternative embodiment, the mask system may include a headgear connector or rigidizer structured to attach to the frame with a snap-fit, mechanical interlock, friction fit, and/or grommet arrangement (e.g., constructed of rubber).


In an alternative embodiment, the mask system may include headgear having an arrangement of straps constructed of silicone and/or Breath-O-Prene™ material.


Other aspects, features, and advantages of this invention will become apparent from the following detailed description when taken in conjunction with the accompanying drawings, which are a part of this disclosure and which illustrate, by way of example, principles of this invention.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings facilitate an understanding of the various embodiments of this invention. In such drawings:



FIG. 1 is a front perspective view of a mask system according to an embodiment of the present invention;



FIG. 1B is a perspective view showing the mask system of FIG. 1 with headgear positioned on a patient's head;



FIG. 1C is a cross-sectional view through the mask system of FIG. 1;



FIG. 1D is another cross-sectional view through the mask system of FIG. 1;



FIG. 1E is a side view of the mask system of FIG. 1;



FIG. 2 is a front perspective view showing the frame and cushion of the mask system of FIG. 1;



FIG. 3 is an exploded perspective view of the mask system of FIG. 1 showing the frame, cushion, shroud, and elbow;



FIG. 4 is another exploded perspective view of the mask system of FIG. 1 showing the frame, cushion, and shroud;



FIG. 5 is an exploded perspective view of the mask system of FIG. 1 showing the shroud and assembled frame/cushion;



FIG. 6 is a front perspective view showing the shroud of the mask system of FIG. 1;



FIG. 7 is a front perspective view showing the cushion of the mask system of FIG. 1;



FIG. 8 is a cross-sectional view showing a portion of the cushion of FIG. 7;



FIG. 8B is a cross-sectional view through nasal bridge and chin regions of the cushion of FIG. 7;



FIG. 9 is a plan view of headgear laid out flat according to an embodiment of the present invention;



FIG. 10 is a front perspective view of a mask system according to another embodiment of the present invention;



FIG. 11 is a front perspective view showing the frame of the mask system of FIG. 10;



FIG. 12 is a front view showing the frame of the mask system of FIG. 10;



FIG. 13 is a side view showing the frame of the mask system of FIG. 10;



FIG. 14 is a front perspective view showing the shroud of the mask system of FIG. 10;



FIG. 15 is a front view showing the shroud of the mask system of FIG. 10;



FIG. 16 is a side view showing the shroud of the mask system of FIG. 10;



FIG. 17 is a rear perspective view showing the shroud of the mask system of FIG. 10;



FIGS. 18-1 to 18-2 are cross-sectional views showing in sequential relation attachment of the shroud to the frame of the mask system of FIG. 10;



FIGS. 19-1 to 19-4 are cross-sectional views showing in sequential relation attachment of the shroud to the frame of the mask system of FIG. 10;



FIG. 20 is a perspective view showing an alternative arrangement for attaching the shroud to the frame;



FIG. 21 is a rear perspective view showing the shroud of the mask system of FIG. 10;



FIG. 22 is a cross-sectional view showing attachment of the shroud to the frame of the mask system of FIG. 10;



FIG. 23 is a cross-sectional view showing attachment of the shroud, frame, and elbow of the mask system of FIG. 10;



FIG. 24 is a cross-sectional view showing an alternative arrangement for attaching the shroud to the frame;



FIG. 25 is a front perspective view of a mask system according to another embodiment of the present invention;



FIG. 26 is a rear perspective view of the mask system of FIG. 25;



FIG. 27 is a front perspective view of a mask system according to another embodiment of the present invention;



FIG. 28 is an exploded view of the mask system shown in FIG. 27;



FIG. 29 is an enlarged front perspective view of the mask system shown in FIG. 17;



FIG. 30 is a side view of the mask system shown in FIG. 27;



FIGS. 31-1 is a rear view of a cushion according to an embodiment of the present invention;



FIG. 31-2 is a front view of the cushion shown in FIG. 31-1 with a partial cut-away;



FIG. 31-3 is a cross-section view through line 31-3-31-3 in FIG. 31-1;



FIG. 31-4 is a cross-section view through line 31-4-31-4 in FIG. 31-1;



FIG. 31-5 is a cross-section view through line 31-5-31-5 in FIG. 31-1;



FIGS. 32-1 to 32-3 illustrate top, front, and side views respectively of a concertina section according to an embodiment of the present invention;



FIG. 33 is a side view of a mask system according to a variation of the present invention;



FIG. 34 illustrates a cushion including a concertina section according to an embodiment of the present invention;



FIGS. 35-1 to 35-3 are front, side, and rear views of a mask system according to another embodiment of the present invention;



FIG. 36 is a perspective view of a shroud for a mask system according to an embodiment of the present invention;



FIGS. 37-1 to 37-3 are perspective, front, and side views of a mask system according to another embodiment of the present invention;



FIGS. 38-1 to 38-5 are perspective, front, top, side, and bottom views of a shroud of the mask system shown in FIGS. 37-1 to 37-3;



FIGS. 39-1 to 39-6 are perspective, front, side, bottom, and top views of a mask system according to another embodiment of the present invention;



FIGS. 40-1 and 40-2 are perspective and side views of a mask system according to another embodiment of the present invention;



FIG. 40-3 is a perspective view of the frame of the mask system shown in FIGS. 40-1 and 40-2;



FIGS. 40-4 and 40-5 illustrate a retaining member of the frame shown in FIG. 40-3;



FIGS. 40-6 and 40-7 illustrate a clip-on upper headgear connector of the mask system shown in FIGS. 40-1 and 40-2;



FIGS. 41-1 and 41-2 are rear and front perspective views of a mask system according to another embodiment of the present invention;



FIGS. 41-3 and 41-4 are exploded views of the mask system shown in FIGS. 41-1 and 41-2;



FIGS. 41-5 to 41-12 are various views of a clip-on upper headgear connector of the mask system shown in FIGS. 41-1 and 41-2;



FIG. 42-1 is a rear perspective view of a mask system according to another embodiment of the present invention;



FIG. 42-2 is an exploded view of the mask system shown in FIG. 42-1;



FIGS. 42-3 to 42-7 are various views of a clip-on upper headgear connector of the mask system shown in FIG. 42-1;



FIGS. 43-1 to 43-4 are perspective, side, front, and rear views of a mask system according to another embodiment of the present invention;



FIG. 44 illustrates a mask system according to another embodiment of the present invention; and



FIG. 45 illustrates a mask system according to another embodiment of the present invention.





DETAILED DESCRIPTION OF ILLUSTRATED EMBODIMENTS

The following description is provided in relation to several embodiments or examples which may share common characteristics and features. It is to be understood that one or more features of any one embodiment or example may be combinable with one or more features of the other embodiments or examples. In addition, any single feature or combination of features in any of the embodiments or examples may constitute additional embodiments or examples.


In this specification, the word “comprising” is to be understood in its “open” sense, that is, in the sense of “including”, and thus not limited to its “closed” sense, that is the sense of “consisting only of”. A corresponding meaning is to be attributed to the corresponding words “comprise”, “comprised” and “comprises” where they appear.


The term “air” will be taken to include breathable gases, for example air with supplemental oxygen.


The term “shroud” will be taken to include components that partially or fully cover a second component within the illustrated embodiments. In an embodiment, the shroud may include the component that partially covers or is mounted on the frame components of the illustrated embodiments.


The term “positive connection” will be taken to include connections between components of the illustrated embodiments wherein connectors mounted on respective components are adapted to engage each other respectively.


1. Mask System


Embodiments of the invention are directed towards a mask system provided without a forehead support adapted to engage the patient's forehead. Such arrangement provides the mask system with a less obtrusive arrangement which does not significantly affect the patient's field of view. Although the system is designed such that a forehead support is not required, such a forehead support can be added if desired.


As described in greater detail below, the mask system includes a frame, a cushion provided to the frame and adapted to form a seal with the patient's face, a shroud provided to the frame and adapted to attach headgear, and an elbow provided to the frame and adapted to be connected to an air delivery tube that delivers breathable gas to the patient. Headgear may be removably attached to the shroud to maintain the mask system in a desired adjusted position on the patient's face. The mask system is intended for use in positive pressure therapy for users with Obstructive Sleep Apnea (OSA) or another respiratory disorder.


While each embodiment below is described as including a full-face or oro-nasal interface type, each embodiment may be adapted for use with other suitable interface types. That is, the interface type is merely exemplary, and each embodiment may be adapted to include other interface types, e.g., nasal interface, nasal mask, nasal prongs, etc.


2. Stabilizing Mechanisms


The stabilizing mechanisms (e.g., frame, shroud, headgear with associated headgear vectors) of a mask system according to embodiments of the invention are structured to accommodate the elimination of a forehead support from a full-face type interface. For example, a forehead support typically eliminates rotation of the mask system in the sagittal and coronal planes, so the mask system and headgear according to embodiments of the invention are structured to take on these functions since there is no forehead support.


The headgear is connected to the top and bottom of the frame either directly or via the shroud, which shroud provides headgear connection points for headgear positioned and arranged to stably maintain the mask system in position on the patient's face.


2.1 Frame


As shown in FIGS. 1, 1B-1E, and 2-5, the frame 1040 of the mask system 1010 is structured to maintain the cushion 1060, shroud 1020, and elbow 1070 in an operative position with respect to the patient's face. The frame 1040 is constructed (e.g., injection molded) from a more rigid material (e.g., polyurethane) than the cushion 1060 (made of, e.g., silicone), however other materials may function likely as well (e.g., polycarbonate). In an embodiment, the frame has a general wall thickness of about 1-2 mm, e.g., 1.5 mm.


The frame 1040 defines a breathing chamber or cavity adapted to receive the patient's nose and mouth and provide air communication to the patient. One or the lower portion of the frame 1040 includes an opening 1046 adapted to receive or otherwise communicate with the elbow 1070 (e.g., swivel elbow) and another or upper portion of the frame 1040 includes a vent arrangement 1076 for gas washout. In addition, the upper portion of the frame 1040 includes an interfacing structure 1048 adapted to interface or otherwise removably connect to the shroud 1020.



FIGS. 27-30 shows a mask system 10 including a frame 40 with a cushion 44 that provides a sealing portion or sealing ring adapted to form a seal with the patient's nose and/or mouth. Also, the frame 40 includes an opening 46 that is adapted to communicate with the elbow 70.


2.2 Shroud


As shown in FIGS. 1 and 3-6, the shroud 1020 is connected to the frame 1040 and is structured to attach headgear to the mask system. In an embodiment, the shroud 1020 is constructed (e.g., injection molded) of a resilient material including but not limited to plastic or nylon (e.g., Nylon 12). However, the shroud may be constructed of other suitable materials, e.g., polycarbonate, polypropylene, thermoplastic elastomer (TPE), Pocan®, etc. In an embodiment, the shroud has a general wall thickness of about 1-2 mm, e.g., 1.3 mm.


The top end of the shroud 1020 is adapted to be positioned proximal to the nasal bridge region or nose of the patient and the bottom end is adapted to be positioned proximal to the mouth or chin of the patient. The top end includes an opening or vent receiving hole 1021 to accommodate the vent arrangement 1076 that protrudes from the frame 1040, and the bottom end includes an opening or elbow hole 1032 to accommodate the elbow 1070 and elbow opening into the frame 1040 (e.g., shroud provides no contact with elbow when assembled).


Upper headgear connectors 1024 extend from each side of the top end, and lower headgear connectors 1025 extend from each side of the lower end. The headgear connectors 1024, 1025 may be integrally molded or otherwise attached to the shroud.


2.2.1 Upper Headgear Connectors


Each upper headgear connector 1024 includes an elongated arm 1026 and a slot or receiving hole 1027 at the free end of the arm 1026 adapted to receive a respective headgear strap. In use, the arms 1026 extend around the face of the patient in a generally concave angle below the eyes of the patient so as to avoid the patient's field of view, i.e., direct headgear away from the patient's eyes. For example, as shown in FIG. 1E, each arm 1026 may extend at an angle α between about 10-25° (e.g., 17°) with respect to horizontal. That is, each arm 1026 is suitably formed, shaped, or contoured to follow the contours of the patient's face and avoid line of sight in use. In an embodiment, the shape of the arms may be generally arcuate and adapted to extend in a direction across the cheek of the patient, while avoiding the eyes or limiting the field of vision. In an embodiment, the arms may be integrally molded to the shroud of the mask system. One possible advantage of molding the arms onto the shroud is that it greatly increases manufacturability and also the shroud may be easily replaced in the case of accidental breakage of the arms rather than replacing the complete mask system. Additionally, molding of the arms onto the shroud may greatly increase the strength of the connection and reduce or limit the actual likelihood of breakage of the arms.


In an embodiment, the arms 1026 are at least semi-rigid (e.g., relatively rigid) so as to prevent up and down movement or bending of the arms relative to the face of the patient. Thus, the arms 1026 may act as rigidizers to effectively act as a level arrangement and generate a mechanical advantage wherein the pressure or force applied to top end of the mask system is readjusted to a fulcrum point being about the center of balance between the top and bottom ends of the mask system. In an embodiment, the arms are attached to the highest possible point relative to the mask system to additionally stabilize the configuration. In an embodiment, the fulcrum point or moment of pivoting is positioned between the upper and lower connection points of the straps, and wherein the design, angle, length and/or configuration of the arms 1026 may effectively adjust the fulcrum point. In the illustrated embodiment, the fulcrum point is shown to be between the vent arrangement and elbow of the mask system. Additionally, when positioned on the face, the mask system may have a fulcrum point around or about the region between the bottom of the patient's nose and lip area. This feature effectively stabilizes the mask system on the patient's face without the traditional need for a forehead support.


The net result of the arms 1026 mounted in a position extending from the top end of the mask system around the face of the patient is that the mask system is more stable and reduces the net torsional forces experiences about the x-axis 1001 (see FIG. 1) for the mask system in use. Please note that the arms 1026 may be rigidly connected to the mask system in other suitable positions to generate a similar result.


In an embodiment, the arms 1026 may be used to stabilize the mask system by contacting the patient's face at the cheeks. A cheek pad may be provided to the inner surface of the arm to support the arm on the patient's cheek in use. Also, the arms 1026 may be enveloped in a soft fabric sleeve to act as additional padding against the cheeks of the patient. The soft fabric sleeve may be in the configuration of an elastic tube covering a portion of the arms 1026.


2.2.2 Lower Headgear Connectors


Each lower headgear connector 1025 includes an abbreviated arm and a clip receptacle 1031 at the free end of the arm adapted to be removably interlocked with a headgear clip associated with a respective headgear strap. The clips allow for easier positioning or donning/removal of the mask system. In an embodiment, the abbreviated arms and clips are also relatively rigid so as to prevent lateral movement of the arms along the y-axis 1002, relative to the mask system in use.



FIGS. 27-30 illustrate an exemplary headgear clip 33 adapted to be removably interlocked with a clip receptacle 31. As best shown in FIG. 28, each clip 33 includes two spring arms 35 adapted to interlock with the respective clip receptacle 31 with a snap-fit and a slot 37 adapted to receive a respective headgear strap in use.


2.2.3 Alternative Headgear Connectors


As shown in FIGS. 27-30, the arm 26 may be removably coupled to the shroud, e.g., arm 26 includes clip structure adapted to removably interlock with a clip receptacle provided to the shroud. This arrangement allows different styles of upper and lower headgear connectors to be used with the shroud, e.g., arms for both upper and lower headgear connectors, clips for both upper and lower headgear connectors, different length arms for upper and lower headgear connectors, etc.


However, the shroud may provide other suitable arrangements for attaching headgear straps of headgear. Also, the shroud may include one or more additional components, e.g., forehead support.


2.2.4 Headgear Connector Positioning


In the embodiment of FIGS. 1-6, the upper and lower headgear connectors 1024, 1025 provide headgear connection points that are as far from each other as possible (i.e., top and bottom of frame) to allow for greater adjustability (e.g., allows adjustment at the top and bottom of the mask system) and stability (e.g., anchor points spread out around the mask system so more secure on the patient's face). Also, the upper headgear connectors are positioned as close to the top of the mask system as possible without obstructing the patient's eyes in use.


2.2.5 Separate Shroud


In the embodiment of FIGS. 1-6, the shroud 1020 is formed separately (e.g., molded) and attached to the frame 1040. Such arrangement facilitates molding of the shroud, allows different materials to be used for the frame and shroud (e.g., frame can be semi-rigid or rigid for stability and shroud with headgear rigidizers can be flexible for adjustment, allows the shroud to hide elbow retention features around elbow/frame opening for retaining elbow to frame (e.g., provides visual shroud for aesthetics), allows frame to be free of lower clip receptacles, allows shroud to be used with different size frames, and allows the shroud to be designed or stylized to minimize obtrusiveness of the mask system. The separate shroud may also allow the headgear, frame, cushion, and/or elbow to be replaced or washed independently.


2.2.6 Sleeves


In an embodiment, soft fabric sleeves may be mounted on the upper and/or lower headgear connectors. For example, the sleeves may be elastic and adapted to slide over the arms of the headgear connectors to form a tight fit. In an embodiment, the sleeves form elastic tubes. The sleeves may be padded to increase the comfort of the mask system in use. The sleeves may be particularly useful where the arms of the headgear connectors contact the patient's skin, e.g., to protect the patient's skin from irritation.


2.2.7 Arm Extends Over the Patient's Ear



FIGS. 35-1 to 35-3 and 36 illustrate a shroud 220 for mask system 210 according to another embodiment of the present invention. The shroud 220 includes an annular retaining portion 222 structured to retain the frame 240 and upper and lower headgear connectors 224, 225 on each side of the retaining portion 222. In the illustrated embodiment, the shroud 220 is integrally formed in one piece (e.g., see FIG. 36).


In the illustrated embodiment, each upper headgear connector 224 includes an elongated arm 226 and a slot 227 at the free end of the arm 226 adapted to receive a respective rear strap 298 in use. As illustrated, the arm 226 is suitably contoured to extend along the cheeks and over the patient's ear just anterior of the patient's temple and retain the respective rear strap 298 in spaced relation over the patient's ear, e.g., to avoid the strap rubbing or irritating the patient's ear in use.


Also, each arm 226 is structured to extend along and engage an upper strap 292 of the headgear in use. As illustrated, each arm 226 is secured to the upper strap 292 to add rigidity to the strap and stabilize the mask system on the patient's face in use. In addition, the strap 292 provides padding to the arm 226 on the patient's face in use. In an embodiment, the upper strap 292 may be fixed to the arm 226 by gluing or stitching for example. Alternatively, the arms 226 may be encapsulated by or inserted into respective straps 292 so that the arms 226 are substantially not visible.


Each lower headgear connector 225 includes an abbreviated arm 228 with a slot 229 at the free end of the arm 229 adapted to receive a respective lower strap 294 in use. As illustrated, the arm 228 is suitably oriented to retain the respective lower strap 294 in spaced relation under the patient's ear, e.g., to avoid the strap rubbing or irritating the patient's ear in use.


In an embodiment, each arm may be attached to the upper end of the mask system and curves below the patient's field of vision or eyes and curves upwards at an angle between about 10 to 20 degrees away from the horizontal axis.


In an alternative embodiment, as shown in FIG. 36, each lower headgear connector 225 may include a clip receptacle 231 adapted to be removably interlocked with a headgear clip (not shown) associated with a respective lower strap 294. In an embodiment, the headgear clip receptacle and clip may be similar to that on ResMed's Mirage Liberty™ mask. Exemplary clip arrangements are disclosed in U.S. Patent Publication Nos. 2007/0144525 and 2006/0283461, each of which is incorporated herein by reference in its entirety.


2.2.8 Shroud Without Upper Headgear Connector



FIGS. 37-1 to 37-3 illustrate a mask system 310 according to another embodiment of the present invention. As illustrated, the mask system 310 includes a shroud 320, a frame 340, a cushion 344, and an elbow 370.


As best shown in FIGS. 38-1 to 38-5, the shroud 320 includes an opening 322 structured to receive the elbow 370 and a headgear connector 325 on each side thereof. In the illustrated embodiment, each headgear connector 325 includes a clip receptacle 331 adapted to be removably interlocked with a headgear clip (not shown) associated with a respective lower headgear strap.


The frame 340 is removably attached to the shroud 320, e.g., fingers and tabs 345 extending from opening 322 adapted to engage collar of frame 340.


The frame 340 includes an upper headgear connector 324 on each upper side thereof. Each headgear connector 324 includes a clip retainer 333 adapted to be removably interlocked with a headgear clip (not shown) associated with a respective upper headgear strap.



FIGS. 39-1 to 39-6 illustrate an alternative version of the mask system 310, which is indicated with similar reference numerals. As illustrated, the frame 340 is provided without upper headgear connectors, and the each clip receptacle 331 includes an alternative configuration (e.g., holes for snap-fit tabs on the clip). Also, the shroud 320 in FIGS. 39-1 to 39-6 includes support bars 329 structured to wrap around respective auxiliary ports 343, while the shroud 320 in FIGS. 37-1 to 38-5 includes support bars 329 that extend in front of respective auxiliary ports 343.


2.3 Headgear


Headgear may be removably attached to the headgear connectors 1024, 1025 of the shroud 1020 to maintain the mask system 1010 in a desired position on the patient's face, e.g., see FIG. 1B.


As shown in FIG. 9, the headgear 1090 includes a pair of upper and lower straps 1092, 1094 with the upper straps 1092 removably attached to respective upper headgear connectors 1024 and the lower straps 1094 removably attached to respective lower headgear connectors 1025. The free end of each strap may include a Velcro® tab structured to engage the remainder of the strap to secure the strap in place. Such Velcro® attachment also allows adjustment of the length of the straps. However, the upper and lower headgear straps may be secured to the shroud in any other suitable manners, e.g., adjustable ladder-lock arrangement, etc.


The upper straps 1092 split at the crown of the patient's head to top straps 1096 (e.g., connected to one another by a buckle) adapted to pass over the top of the patient's head in use and rear straps 1098 adapted to pass behind the patient's head in use. In an embodiment, the headgear 1090 is structured to be self-supporting.


In FIG. 9, the top straps 1096 are adapted to be connected to one another by a buckle. In an alternative embodiment, as shown in FIG. 27-30, headgear 90 may include upper and lower straps 92, 94, top strap 96, and rear strap 98, with the top straps 96 integral with one another.


The upper straps 1092 are designed to adjust the position of the mask in a similar way that an adjustable forehead support would alter the position of the mask system, i.e., move the top of the mask system closer or further away from the patient's nasal bridge.


Without the forehead support, the headgear is connected at the top and bottom of the mask frame 1040 via the shroud 1020, and in order to avoid the eyes and ears, the arm 1026 of the upper headgear connector extends at an angle. In doing so, the headgear vectors V1 and V2 (see FIGS. 1 and 1B) are aligned such that the mask system may have a tendency to ride up the patient's face (i.e., upper headgear connectors position upper headgear vectors upwardly from horizontal and lower headgear connectors position lower headgear vectors generally horizontal). By splitting the upper headgear strap 1092 at the crown of the patient's head (i.e., top and rear straps 1096, 1098), the upper headgear vectors are realigned to prevent the mask system from sliding up the patient's face.


2.3.1 Headgear Adjustment



FIGS. 35-1 to 35-3 illustrate headgear 290 attached to the headgear connectors 224, 225 of the shroud 220 to maintain the mask system in a desired position on the patient's face.


In the illustrated embodiment, the headgear 290 includes a pair of upper or top straps 292, a pair of lower or bottom straps 294, and a pair of rear straps 298. In use, the upper straps 292 are secured to respective upper connectors or arms 226, the lower straps 294 are removably attached to respective lower connectors via slots 229/clip arrangement 231, and the rear straps 298 are removably attached to respective upper connectors via slots 227. The upper straps 292 may include upper strap portions adapted to pass over the top of the patient's head and couple to one another, e.g., via a headgear buckle or adjustable ladder-lock arrangement 299. In the illustrated embodiment, the lower straps 294 and rear straps 298 are formed in one piece.


This headgear arrangement allows adjustment to occur at three positions, i.e., upper straps 292 at the headgear buckle 299, lower straps 294 at the slot 229/clip 231 connection, and rear straps 298 at the slot 227 connection.


As illustrated, the free end of each strap may include a hook and loop tab 295 (e.g., Velcro®) structured to engage the remainder of the strap to removably secure the strap in place. Such hook and loop attachment also facilitates adjustment of the length of the straps.


In the illustrated embodiment, the lower straps 294 and rear straps 298 are adapted to join and pass behind the patient's head in use (e.g., see FIG. 35-3). As illustrated, the lower straps 294 join at an angle α (e.g., similar to the bottom strap in ResMed's Mirage Liberty mask) to prevent the strap from irritating the patient's neck and/or prevent movement of the strap due to movement of the patient's neck in use.


In an embodiment, the headgear may be similar to that for ResMed's Mirage Liberty mask, however the top straps have been modified and there is an added rigidizer system. The top straps may be similar to ResMed's Swift style headgear, with the rigidizers extending along the sides.


2.3.2 Alternative Headgear Material



FIGS. 43-1 to 43-4 illustrate a mask system 610 including a mask 615 and headgear 690 according to another embodiment of the present invention. In the illustrated embodiment, the headgear 690 includes an arrangement of straps wherein some of the straps are constructed of silicone and some of the straps are constructed of Breath-O-Prene™ material. However, the headgear may be constructed such that the straps are completely constructed of silicone or completely constructed of Breath-O-Prene™.


As illustrated, the lower strap portion 692 of the headgear is constructed of Breath-O-Prene™ and extends along the cheeks and around the back of the patient's head. The upper strap portion 694 of the headgear is constructed of silicone and includes side straps 694(1) that extend along the upper cheek and over the patient's ear, a top strap 694(2) that extends over the top of the patient's head, rear straps 694(3) that extend behind the patient's head and connects to the lower strap portion 692 (see FIG. 43-4), and connecting portions 694(4) that extend from respective side straps 694(1) in front of the patient's ear and connect to the lower strap portion 692.


The headgear straps may be connected to the mask in any suitable manner. For example, in the illustrated embodiment, the lower strap portion 692 is connected to the mask by a headgear clip arrangement and the upper strap portion 694 is connected to the mask using an elongated buckle 695 with buckle portions on each end thereof.


In an embodiment, the headgear straps are arranged such that the force vectors applied by the headgear to the mask are substantially perpendicular to the mask and substantially parallel to one another (e.g., as shown by the arrows in FIG. 43-2). This arrangement enhances the mask seal as the headgear forces the mask directly into the patient's face.


3. Seal


The seal (i.e., cushion) of the mask system is structured to accommodate the elimination of a forehead support from a full-face type interface.


3.1 Cushion


As shown in FIGS. 1-5 and 7-8, the cushion 1060 is structured to interface with the frame 1040 and form a seal with the patient's nose and mouth in use. In the illustrated embodiment, the cushion is a full-face cushion adapted to engage the patient's face generally along nasal bridge, cheek, and lower lip/chin regions of the patient's face. However, other cushion interfaces are possible, e.g., nasal.


The cushion 1060 is structured be more compliant or flexible (e.g., particularly in the nasal bridge region) to accommodate more movement due to loss of some stability without a forehead support.


The cushion 1060 is constructed of a soft and flexible biocompatible material, e.g., such as silicone. In the illustrated embodiment, the cushion 1060 includes a dual wall configuration wherein the cushion comprises an undercushion or support wall 1062 underneath a membrane 1064 as shown in FIG. 8.


The membrane 1064 is generally softer and less stiff than the undercushion 1062 and provides a seal against the patient's face in use. The membrane may be relatively thin to allow for wider fit range and better conformance to the patient's face in view of less mask stability with a forehead support. The undercushion is structured to generally support the membrane and prevents collapse of the membrane when the mask system is attached and tightened using the headgear.


The membrane 1064 is generally concave and curves inwards towards the breathing chamber. The undercushion 1062 may also curve inwardly but is generally shorter, thicker, and more rigid than the membrane.


In an embodiment, the undercushion 1062 at the regions of the nasal bridge and/or chin of the patient is shorter in height or completely absent and the height from the tip to base of the undercushion 1062 may be between about 0 mm and 30 mm. The membrane is generally longer than the undercushion 1062 at any given cross-section and may be between about 1 mm and 40 mm. For example, FIG. 8B illustrates a cross-section through nasal bridge and chin regions of the cushion to illustrate the membrane 1064 without an undercushion in these regions.


In an embodiment, the undercushion 1062 may only be provided in selected regions of the mask system, e.g., where the mask system is to be pushed away from the patient's face. Certain pre-determined regions of the patient's face may be preferably avoided for applying pressure by the tightening of the headgear. In the illustrated embodiment, the nasal bridge and chin regions of the patient do not include an undercushion 1062. In these regions, the undercushion is only provided along lateral sides of the cushion (e.g., see FIG. 7) which press against the cheeks of a patient so as to more evenly distribute the force vectors applied by the mask system in use. In an embodiment, the undercushion may be relatively stiff along the cheek regions because these points of contact are acting as anchor points, i.e., holds mask system in position to provide effective seal.


This configuration of avoiding the nasal bridge and chin of the patient may increase the comfort of the mask system for patients by reducing the pressure or force applied to sensitive areas or to protruding regions of the patient's face that experience relatively higher contact pressures. Additionally, this arrangement avoids the cushion pinching the nasal bridge of the patient when the mask system is adjusted. Additionally, the cushion of this embodiment may be noticeably softer in the regions of the nasal bridge and chin because of the absence of the undercushion.


In an embodiment, the undercushion may include a variable height, stiffness, and/or thickness to generate a variable softness in the aforementioned predetermined regions of the face that require lighter support.


In the illustrated embodiment, the cushion may be structured to seal lower down on the patient's nasal bridge and the eye sockets so that the cushion is less obtrusive.


In an embodiment, the cushion may be generally frosted except at patient contacting surfaces where it is polished. In an embodiment, the frosting of the cushion may reduce restriction between the face and membrane and/or the membrane and undercushion. The frosting allows the surface of the membrane and undercushion to slide against each other's respective surface without the same restriction of unfrosted silicone. This feature may also prevent or limit sticking of the membrane to the undercushion components and also may generally improve the overall comfort and sealing properties of the cushion. Additionally, the frosting of the cushion may be easier to manufacture and may lead to a reduction of costs of manufacturing. The cushion may be constructed of frosted silicone or other suitable materials.


3.2 Cushion Lower on Nasal Bridge



FIGS. 31-1 to 31-5 illustrate various views of a cushion 44 (e.g., constructed of silicone) according to an embodiment of the present invention. As illustrated, the cushion 44 includes a base wall 44(1) provided to the frame, an undercushion layer (UCL) 44(2) extending away from the base wall 44(1), and a membrane 44(3) provided to substantially cover the UCL 44(2) and provide a sealing structure. In the illustrated embodiment, the cushion 44 is structured to sit lower on the nasal bridge to reduce mask obtrusiveness and improve “line of sight” in use.


Also, as best shown in FIGS. 31-3 and 31-5, the UCL 44(2) design in the nasal bridge region is structured to provide improved stability across the nasal bridge in use. As shown in FIGS. 31-1 and 31-3, the UCL is not provided in the lower lip/chin region. However, other arrangements of the UCL are possible, e.g., UCL around entire perimeter.


In an embodiment of the cushion shown in FIGS. 31-1 to 31-5, D1 may be about 15-20 mm, e.g., 18.2 mm, D2 may be about 53-59 mm, e.g., 55.8 mm, D3 may be about 88-93 mm, e.g., 90 mm, D4 may be about 78-83 mm, e.g., 81.1, D5 may be about 58-63 mm, e.g., 60 mm, D6 may be about 95-100 mm, e.g., 98.1 mm, D7 may be about 57-62 mm, e.g., 59.7 mm, D8 may be about 77-82 mm, e.g., 79 mm, D9 may be about 88-93 mm, e.g., 90.7 mm, D10 may be about 30-35 mm, e.g., 33.1 mm, D11 may be about 14-19 mm, e.g., 16.4 mm, D12 may be about 8-13 mm, e.g., 9.6 mm, D13 may be about 0.3-0.5 mm, e.g., 0.35 mm, D14 may be about 0.4-0.6 mm, e.g., 0.5 mm, and D15 may be about 0.3-0.5 mm, e.g., 0.4 mm Although specific dimensions and ranges are indicated, it is to be understood that these dimensions and ranges are merely exemplary and other dimensions and ranges are possible depending on application. For example, the exemplary dimensions may vary by 10-20% or more or less depending on application.


3.3 Cushion Higher on Nasal Bridge



FIGS. 35-1 and 35-2 illustrate a full-face cushion 244 adapted to engage the patient's face generally along nasal bridge, cheek, and lower lip/chin regions of the patient's face. In this embodiment, the cushion 244 is structured such that it is positioned higher on the bridge of the nose for sealing and comfort (e.g., with respect to the cushion 44 described above). The cushion 244 may also be better for anthropometrics, i.e., the cushion will fit more people.


In an embodiment, the cushion 244 may include a concertina section as described below (e.g., in the nasal bridge region) to enhance the flexibility of the cushion in use.


3.4 Concertina Section


As best shown in FIGS. 30 and 33, a concertina section 50 may be provided in a nasal bridge region of the cushion and/or frame. As illustrated, the concertina section 50 includes a bellows structure with one or more folds 52 that provide a higher degree of flexibility or increased movement. That is, the concertina section 50 provides a higher level of adaptability or flexibility to the nasal bridge region of the cushion/frame which is a more sensitive region of the patient's face in use. Moreover, the concertina section 50 provides increased movement without compromising seal.



FIGS. 32-1 to 32-3 illustrate various views of a concertina section 50 (isolated from the remainder of the cushion/frame) with one or more folds 52 according to an embodiment of the present invention. As best shown in FIG. 32-3, the folds may have different lengths, depths, and/or contours with respect to one another to optimize the concertina effect, e.g., provide sufficient degree of movement without compromising seal. For example, as shown in FIG. 32-3, each fold 52 includes a first side wall 52(1) and a second side wall 52(2) that interconnects adjacent side walls 52(1).


In the illustrated embodiment, the first side walls 52(1) and/or the second side walls 52(2) may become progressively longer away from the patient's face. For example, the first side wall 52(1) and/or the second side wall 52(2) adjacent patient's face, or the combination of side walls 52(1) and 52(2), may have a length that is longer than and in some cases significantly longer than the adjacent side wall 52(1) and/or 52(2) (e.g., one side wall at least 25% greater than and up to 5× as long as the other side wall, e.g., 1×, 2×, 3×, or 4×).


The folds may be constructed and arranged to provide a predetermined order of movement or folding, e.g., folds structured to fold in a sequential or progressive manner wherein one fold collapses before an adjacent fold collapses. For example, upon application of force, the folds closest to the patient's face may fold or collapse before the folds furthest from the patient's face. Also, the folds may be constructed and arranged to provide various degrees of fold or collapse, e.g., folds may fold or collapse more than others.


In an embodiment of the concertina section shown in FIGS. 32-1 to 32-3, D1 may be about 50-60 mm, e.g., 55.7 mm, D2 may be about 5-15 mm, e.g., 9.7 mm, and D3 may be about 0.3-0.5 mm, e.g., 0.4 mm Although specific dimensions and ranges are indicated, it is to be understood that these dimensions and ranges are merely exemplary and other dimensions and ranges are possible depending on application. For example, the exemplary dimensions may vary by 10-20% or more or less depending on application.


It should be appreciated that a concertina section 50 may be provided in other regions of the cushion and/or frame, e.g., depending on patient comfort. For example, the concertina section 50 may be provided around the entire perimeter of the cushion and/or frame or may be provided in selected regions of the cushion and/or frame.


Also, the flexibility of the concertina section 50 may be varied and may be varied in different regions of the cushion and/or frame, e.g., depending on patient comfort. For example, the cushion and/or frame may include a concertina section in the nasal bridge region with a relatively high degree of flexibility and a concertina section in the lower lip/chin region with a relatively low degree of flexibility. The flexibility of the concertina section 50 may be varied by varying the number of folds 52 (e.g., 1-5 folds), the wall lengths, the wall thickness of the folds 52, the depth of the folds 52, etc.


As noted above, the cushion and frame may be co-molded of two parts with different materials/rigidities or may be integrally formed of the same material. In both embodiments, the concertina section may be provided in the frame and/or the cushion.


In FIGS. 27-30, the cushion 44 and frame 40 are co-molded of two parts with the concertina section 50 provided in the frame 40. The frame 40 and cushion 44 include different rigidities in order to optimize the function of each part. For example, one part (i.e., cushion 44) may be constructed of a relatively soft, supple material to optimize the sealing effect and the other part (i.e., frame 40) may be constructed of a more rigid material to provide adequate support for the cushion while at the same time allowing a sufficient degree of movement to optimize the concertina effect. While the frame is more rigid than the cushion, the frame may be constructed of a flexible material to allow the concertina effect.


In FIG. 33, the frame 40 and cushion 44 are integrally formed in one piece with the concertina section 50 provided in the frame 40. The material properties and/or dimensions may be selectively modified to optimize sealing and concertina effects.


For both embodiments of FIGS. 27-30 and 33, it should be appreciated that the concertina section may be alternatively provided in the cushion 44 or in both the frame 40 and cushion 44. For example, FIG. 34 illustrates a concertina section 50 integrally formed with the cushion 44 in the nasal bridge region.


4. Elbow


As shown in FIG. 3, the elbow 1070 (e.g., constructed of a relatively hard material such as polycarbonate or polypropylene) includes a first end portion 1074(1) and a second end portion 1074(2). The first end portion 1074(1) provides an interfacing structure structured to interface or otherwise attach to the frame 1040. The second end portion 1074(2) is adapted to be connected to an air delivery tube.


4.1 Elbow Connection to Frame/Shroud


As shown in FIGS. 27-30, the shroud module 20 is structured to maintain the elbow module 70 in an operative position with respect to the patient's face. That is, the shroud module 20 acts as a carrier and bearing surface for the elbow module 70. The shroud module 20 and elbow module 70 may connect with a friction fit, snap-fit, mechanical interlock, or other suitable attachment mechanism. However, other suitable arrangements for attaching the elbow module to the frame module are possible.


In FIGS. 27-30, the elbow module 70 may be rotatably attached to the shroud module 20 so that the elbow module 70 may be rotated relative to the shroud module 20 in use, e.g., 360° rotation.


The frame 1040 (FIG. 3) is structured to maintain the elbow 1070 in an operative position with respect to the patient's face. That is, the frame acts as a carrier and bearing surface for the elbow. The frame and elbow may connect with a friction fit, snap-fit, mechanical interlock, or other suitable attachment mechanism. However, other suitable arrangements for attaching the elbow to the frame are possible.


In the illustrated embodiment, the elbow 1070 includes a series of tangs 1075 adapted to releasably engage within the opening 1032 of the frame 1040, e.g., with a snap-fit. The tangs 1075 hold the elbow in place (e.g., preferably a relatively airtight connection) and permit rotation or swiveling of the elbow with respect to the frame.


That is, the elbow is rotatably attached to the frame so that the elbow may be rotated relative to the frame in use, e.g., 360° rotation. This arrangement allows the elbow to assume different orientations in use, e.g., depending on patient preference. For example, the elbow may assume a first orientation so that the elbow extends generally downwardly from the mask to direct the air delivery tube under the patient's head in use. Alternatively, the elbow may be rotated and assume a second orientation so that the elbow extends upwardly from the mask to direct the air delivery tube over the patient's head in use. In an embodiment, the frame and elbow may be constructed of dissimilar materials to prevent or at least reduce squeak between the components in use.


The second end portion of the elbow may be provided to a swivel joint adapted to be connected to the air delivery tube. For example, FIGS. 27-30 illustrate a swivel joint 80 provided to the second end portion 74(2) of elbow 70. In the illustrated embodiment, the swivel joint 80 is provided to a short tube 82 (e.g., extendable and retractable tube) that interconnects the elbow with the air delivery tube. In an embodiment, the swivel joint 80 may be integrally formed in one piece with the short tube 82.


4.2 AAV


The elbow 1070 includes a slot 1081 to receive an anti-asphyxia valve (AAV), a port 1079 that is selectively closed by a flap portion of the AAV (depending on the presence of pressurized gas), and structure for attaching the AAV, e.g., with a snap-fit.



FIGS. 27-30 illustrate an exemplary AAV 85 including a flap portion 86 to selectively close port 79 in elbow 70. In this embodiment, a clip portion 88 is provided to the flap portion 86 for attaching the AAV 85 to the elbow 70. In the illustrated embodiment, the flap portion 86 and the clip portion 88 are co-molded with one another to form a one-piece, integrated component. However, the flap portion 86 and clip portion 88 may be secured to one another in other suitable manners, e.g., mechanical interlock.


In an embodiment, the flap portion 86 may be constructed of a relatively soft elastomeric material (e.g., silicone) and the clip portion 88 may be constructed of a more rigid material (e.g., rigid plastic) for interfacing with the elbow 70.


The clip portion 88 of the AAV 85 includes structure for removably interlocking with the elbow 70, e.g., with a snap-fit. For example, the clip portion 88 may include tabs structured to interlock with respective recesses/protrusions provided to the elbow.



FIGS. 35-1 and 35-2 illustrate an elbow 270 including a port 279 that is selectively closed by a flap portion 286 of the AAV 285 (depending on the presence of pressurized gas). Also, FIGS. 37-1 to 37-3 illustrate elbow 370 including a port 379 and a slot 381 to retain the AAV.


Alternative embodiments of the AAV are disclosed in PCT Application No. PCT/AU2006/000031, which is incorporated herein by reference in its entirety.


4.3 Large Diameter End Portion


As shown in FIGS. 27-30, the first end portion 74(1) of the elbow 70 may provide a relatively large diameter which allows the potential for cleaner/smoother lines thereby contributing to the overall mask aesthetic and reduced obtrusiveness. In addition, the relatively large diameter elbow offers the potential for the patient's nose to protrude into the elbow cavity thereby permitting the mask to be brought closer to the patient's face (i.e., reduced obtrusiveness), less moment since center of gravity of mask is closer to the patient's face, and/or improved line of sight.


5. Modular Design


The mask system provides a modular design that allows different styles and/or sizes of the frame (also referred to as a frame module), shroud (also referred to as a shroud module), cushion (also referred to as a cushion module), and/or elbow (also referred to as an elbow module) to be interchanged or mixed and matched with one another to provide a more customized mask system for the patient. In addition, such design allows selected modules to be easily replaced, e.g., treatment requirements change, worn out or damaged, etc.


In an embodiment, the mask system may be provided with a number of different cushions, e.g., each having cushions of different styles and/or sizes (e.g., depending on patient preference and/or fit). For example, the non-face contacting side of each cushion may include a common or universal configuration for interfacing with the frame, and the face-contacting side of the cushion may include different styles and/or sizes. This provides a modular arrangement that allows the frame to be selectively (e.g., and removably) coupled to one of multiple cushion. For example, the different cushions may include different size cushions (e.g., small, medium, and large) and may include a different cushion structures.


In an embodiment, the mask system may be provided with different shrouds, e.g., each shroud having a different style and/or size (e.g., shroud with different arrangement/style of headgear connectors, shroud with forehead support, different headgear vectors, etc).


In an embodiment, the mask system may be provided with different frames, e.g., each frame having a different style and/or size (e.g., frame with different vent arrangement, small, medium, and large size frame, etc).


In an embodiment, the mask system may be provided with a number of different elbows, e.g., each having a vent arrangement, AAV (in the case of an oro-nasal mask), and/or elbow of different styles and/or sizes. In the illustrated embodiment of FIGS. 27-30, the vent arrangement 76 and AAV 85 are structured to be removably attachable to the elbow 70. This provides a modular arrangement that allows the elbow to be selectively and removably coupled to one of multiple vent arrangements and/or AAVs. This also allows the vent arrangement and AAV to be easily replaced, e.g., if damaged.


5.1 Shroud to Frame Connection


The shroud is mounted on the outer surface of the frame, e.g., preferably with a tight, conforming fit on the frame.


5.1.1 Upper Retaining Mechanism


In the illustrated embodiment of FIGS. 1-5, the shroud 1020 is connected to the frame 1040 by an upper retaining mechanism or interfacing structure 1048 located on the top end of the frame and shroud.


As shown in FIGS. 2 to 5, the upper retaining mechanism 1048 is in the form of two taper locks structured to secure the shroud 1020 on the frame 1040 and prevent unintentional disassembly particularly due to headgear forces. In this embodiment, opposing sides of the frame include a female slot 1055 adapted to receive a respective tang protrusion (which tapers along its length) on the underside of the shroud 1020. The tapered protrusion engages within a respective female slot, e.g., with a friction fit.



FIGS. 10 to 19-4 show another embodiment of a mask system 1110 which more clearly illustrates an embodiment of the taper lock. FIGS. 10 to 17 show various views of the frame 1140, shroud 1120, and elbow 1170 of the mask system 1110.


As best shown in FIGS. 11 to 13, opposing sides of the top end of the frame 1140 include a platform 1154 which provides a first female slot 1155(1). In addition, the space between the platform 1154 and the outer surface of the frame 1140 defines a second female slot 1155(2). As best shown in FIG. 17, opposing sides of the top end of the shroud 1120 include a tang protrusion 1156 on the underside of the shroud 1120. The tang protrusion 1156 includes a first tang 1156(1) and a second tang 1156(2) that extends generally transverse to the first tang 1156(1). As shown in FIGS. 18-1 and 18-2, each tang may taper along its length, i.e., thinner towards its free end.



FIGS. 18-1 and 18-2 and 19-1 to 19-4 sequentially illustrate attachment of the shroud 1120 to the frame 1140. As illustrated, the tangs 1156(1), 1156(2) of each tang protrusion 1156 are structured to engage with respective slots 1155(1), 1155(2), e.g., with a friction fit. As best shown in FIGS. 19-1 to 19-4, each slot 1155(2) includes lead-ins or guides 1157 that curve along their length (i.e., extend in vertical and horizontal direction) so as to guide the tang 1156(2) into the slot 1155(2) and aid assembly. FIGS. 18-2 and 19-4 show the tangs 1156(1), 1156(2) when fully inserted with respective slots 1155(1), 1155(2).


In an alternative embodiment, as shown in FIG. 20, the upper retaining mechanism may include a clip-type arrangement. As illustrated, opposing sides of the top end of the frame 1240 provide a shoulder 1255(1) and a tapered protrusion 1255(2). Opposing sides of the top end of the shroud 1220 include a first tang 1256(1) and a second tang 1256(2) on the underside of the shroud 1220. In use, each first tang 1256(1) is engaged with the respective shoulder 1255(1) and the second tang 1256(2) is engaged or clipped onto the tapered protrusion 1255(2), e.g., with a snap-fit.


5.1.2 Lower Retaining Mechanism


In an embodiment, the shroud may also be connected to the frame by a lower retaining mechanism located on the bottom end of the frame and shroud. For example, a retaining mechanism may be provided to the opening of the shroud which is structured to interlock or otherwise engage with the opening of the frame.


For example, as shown in FIGS. 14, 15, 17, and 21, the opening 1132 of the shroud 1120 may include structure adapted to engage the collar 1149 surrounding the frame opening 1146 with a snap-fit. As illustrated, the shroud 1120 includes snap fingers 1145(1) (e.g., three snap fingers) and sandwich tabs 1145(2) (e.g., three sandwich tabs) that extend from the opening 1132. The snap fingers and sandwich tabs are alternatively spaced about the opening.


In use, the snap fingers 1145(1) resiliently deflect (e.g., 0.5 mm deflection) and engage respective part-annular protrusions 1149(1) provided to the collar 1149 (e.g., see FIGS. 22 and 23) to provide an initial retention of the shroud 1120 to the frame 1140 (e.g., with allowable stresses), e.g., to facilitate assembly and disassembly. In addition, as the snap fingers 1145(1) engage respective protrusions 1149(1), the sandwich tabs 1145(2) are received in respective recesses 1149(2) provided to the end of the collar 1149 (e.g., see FIGS. 22 and 23). When the elbow 1170 is engaged with the frame 1140 (e.g., see FIG. 23), an annular protrusion 1171 on the elbow 1170 is positioned on an opposing side of the sandwich tabs 1145(2) so that the sandwich tabs 1145(2) are sandwiched between the collar 1149 and the elbow 1170. Thus, the sandwich tabs utilize elbow retention forces to retain the shroud on the frame during use. The elbow 1170 has a distal shoulder 1173 adapted to extend under the edge of the frame 1140 to retain the elbow to the frame. The snap fingers 1145(1) allow the shroud to connect to the frame independent of the elbow.


In an alternative embodiment, as shown in FIG. 24, the shroud's lower section may be structured to clip to a single point below the collar. As illustrated, the lower end of the shroud 1320 includes a snap finger 1345 that is engaged or clipped onto a protrusion 1349(1) spaced below the collar 1349 of the frame 1340, e.g., with a snap-fit. In this embodiment, the protrusion 1349 extends from the cover enclosing auxiliary ports. This arrangement may facilitate molding of the collar on the frame, e.g., uniform thickness of the collar prevents molding distortions. In addition, removal of the protrusions 1149(1)/recesses 1449(2) from the collar may reduce the risk of leak.


5.1.3 Finger Grip


In an embodiment, the outer surface of the frame 1040 may include finger grips or recessed portions 1097, which are positioned to be exposed under the shroud 1020. The finger grips are adapted to allow the patient an improved ability to grip the frame and/or shroud which is particularly useful when disengaging the shroud from the frame.


5.1.4 Alternative Interfacing Structure


In an alternative embodiment, as shown in FIG. 27-30, the shroud 20 includes an open construction that provides an annular or part annular retaining portion 22 structured to retain the frame 40 and the elbow 70. As illustrated, the annular retaining portion 22 includes an interfacing structure 23 along an inner edge that is adapted to interface with or otherwise removably connect to an interfacing structure 48 along the outer perimeter of the frame 40 (e.g., see FIG. 28). In the illustrated embodiment, the interfacing structure 23 is in the form of opposed flanges 23(1) that are adapted to interlock with respective locking structures 48(1) provided on opposing sides of the frame 40. However, other suitable arrangements for attaching the frame 40 to the shroud 20 are possible, e.g., friction fit, snap-fit, mechanical interlock, or other suitable attachment mechanism.


For example, the frame 40 may be coupled to the shroud 20 in a manner that allows the frame 40 to be locked in different angular positions with respect to the shroud 20, e.g., pivotally mounted.


5.1.5 Alternative Upper Headgear Connector



FIGS. 40-1 to 40-7 illustrate a frame and a clip-on upper headgear connector or rigidizer according to another embodiment of the present invention.


The frame 442 includes an opening 449 adapted to engage a frame shroud and/or elbow. Around and under the opening 449 is the u-shaped slot 402 for gas washout and auxiliary ports 443 on each side thereof.


In this embodiment, each upper side of the frame 442 includes a retaining member 433 and an upper intermediate portion of the frame 442 includes retaining grooves 435, which are structured and arranged to retain an upper headgear connector or rigidizer 424.


As best shown in FIGS. 40-6 and 40-7, the upper headgear connector 424 includes a pair of elongated arms or rigidizers 426 coupled by a pair of wire members 428. Each rigidizer 426 includes a slot 427 at its free end adapted to receive a respective headgear strap in use.


In use, the upper headgear connector 424 is adapted to clip onto the frame 442 (e.g., see FIGS. 40-1 and 40-2). Specifically, intermediate portions of the wire members 428 are received in respective grooves 435 of the frame 442, and end portions of the wire members 428 extend through respective retaining members 433 with the rigidizers 426 providing a shoulder to interlock with respective retaining members 433. FIGS. 40-4 and 40-5 show an upper portion of a retaining member 433 to illustrate the groove 433(1) adapted to receive a respective wire. As illustrated, the end of the groove 433(1) includes tapered side walls 433(2) and drops off towards a rear side 433(3) to position the rigidizers 426 into interlocking engagement with the retaining member 433.



FIGS. 41-1 to 41-12 illustrate an upper portion of a frame and a clip-on upper headgear connector or rigidizer according to another embodiment of the present invention.


As illustrated, the upper portion of the frame 542 includes a retaining member 533 on each side thereof and a retaining groove 535 along an intermediate portion thereof, which are structured and arranged to retain an upper headgear connector or rigidizer 524.


As best shown in FIGS. 41-5 and 41-12, the upper headgear connector 524 includes a pair of elongated arms or rigidizers 526 coupled by a connecting portion 528. Each rigidizer 526 includes a slot 527 at its free end adapted to receive a respective headgear strap in use. In addition, the upper headgear connector 524 includes a clip structure 525 on each side of the connecting portion 528.


In use, the upper headgear connector 524 is adapted to clip onto the frame 542 (e.g., see FIGS. 41-1 and 41-2). Specifically, the connecting portion 528 is received in the groove 535 of the frame 542, and the clip structures 525 releasably interlock with respective retaining members 533. As best shown in FIGS. 41-3 and 41-4, each retaining member 533 provides a cross-bar, and each clip structure 525 provides a v-shaped configuration that is adapted to resiliently deflect through the cross-bar and provide a shoulder to releasably interlock with the cross-bar.



FIGS. 42-1 to 42-7 illustrate an alternative embodiment for engaging the upper headgear connector with the frame. As illustrated, each retaining member 533 provides an open-ended cross-bar, and each clip structure 525 provides an elongated arm. In this embodiment, the cross-bar is structured to resiliently deflect to allow the clip structure 525 to extend through the cross-bar and releasably engage the cross-bar, e.g., with a friction fit. In addition, the upper headgear connector 524 of FIGS. 42-1 to 42-7 includes a c-shaped clip structure 529 adapted to interlock with a tab 549 provided to the frame 542 (see FIGS. 42-1 and 42-2).


5.1.6 Grommet Attachment



FIGS. 44 and 45 illustrate an alternative mask arrangement in which the shroud is attached to the frame via a grommet.


For example, as shown in FIG. 44, the frame 740 includes a grommet 745 (e.g., constructed of a rubber) and the shroud 720 includes an opening 725 adapted to receive the grommet 745 to secure the shroud 720 to the frame 740. As illustrated, the shroud 720 includes elongated upper and lower arms 724, 726 each with a slot 727 at its free end adapted to receive a respective headgear strap in use.



FIG. 45 illustrates an alternative shroud 820 which includes a single arm with a slot 827 at each end adapted to receive a respective headgear strap in use. In addition, the shroud 820 provides an elongated inner slot 825 adapted to receive the grommet 745 of the frame 740. The elongated slot 825 allows the grommet 745 to be fixed in one of multiple positions along the length of the slot 825, in contrast to the shroud 720 which provides a single fixed position. In an embodiment, the shroud 820 may be slidable with respect to the grommet 745 to allow an infinite number of positions with respect to the frame 740.


In each embodiment, the grommet 745 (e.g., constructed of a rubber) fixes the shroud in position but the inherent flexibility of the grommet provides a flexible connection to decouple the shroud from the frame and allow a range of movement between the two components, e.g., like a ball joint or gimbal. Such arrangement helps with fitting and sealing of the mask to the patient's face. That is, the flexible connection allows the mask to selectively adjust and/or self-fit with the patient's face.


5.2 Cushion to Frame Connection


In FIGS. 1-8, the non-face contacting side of the cushion 1060 is connected to frame 1040 in a tongue and groove relationship. The tongue 1066 (see FIGS. 1C, 1D, and 8) of the cushion 1060 is inserted within a groove 1041 (see FIGS. 1C and 1D) provided along the perimeter of the frame 1040. The tongue and groove relationship may also include a locking lip or sealing lip 1068 (see FIGS. 1C, 1D, and 8) on the cushion that is adapted to interlock with an undercut bead 1042 (see FIGS. 1C and 1D) within the frame groove to fixably retain the cushion to the frame.


In the illustrated embodiment, the cushion 1060 also includes one or more positioning features located around its circumference to assist with proper alignment of the cushion with the frame 1040. As shown in FIG. 7, the cushion 1060 includes notches and/or protrusions (e.g., two notches 1067 and one protrusion 1069) adapted to engage with complementary features in the frame, e.g., interlocking relationship.


5.2.1 Co-Molding Frame and Cushion


In an embodiment, as shown in FIGS. 27-30, the frame 40 and cushion 44 may be co-molded with one another to form a one-piece, integrated component. For example, the frame 40 may be molded of a first material adapted to interface with the shroud 20 and the cushion 44 may be co-molded onto the frame 40 of a second material adapted to interface with patient's face.


In such embodiment, the cushion 44 may be constructed of a relatively soft elastomeric material (e.g., silicone) for sealing and the frame 40 may be constructed of a more rigid material than the cushion 44 (e.g., polycarbonate, polypropylene) for interfacing with the frame.


Co-molding the frame 40 to the cushion 44 provides a chemical bond without necessarily forming a mechanical interlock. As a result, the connection includes no cracks, a gas tight seal, and clean interface. Moreover, such co-molded connection relaxes tolerances as the mold materials are sufficiently flexible to fill in any gaps at the interface between the frame 40 and the cushion 44. Also, the co-molded frame/cushion provides a reduced part count (reduced cost) and facilitates assembly/disassembly to the shroud 20.


In an alternative embodiment, as shown in FIG. 33, the frame 40 and cushion 44 may be integrally formed in one piece, e.g., of a silicone material. That is, the frame 40 may have the same shape and structure as described above, but be integrally molded of the same material, e.g., silicone.


In an embodiment, the integrally formed frame 40/cushion 44 may be co-molded to the shroud 20, e.g., constructed of polycarbonate or polypropylene. For example, the shroud 20 may be constructed of a relatively rigid material (e.g., polycarbonate or polypropylene) and the frame 40/cushion 44 may be co-molded onto the shroud 20 of a relatively soft elastomeric material (e.g., silicone).


5.3 Vent Arrangement


In FIGS. 1, 1B, 1C, 1D, and 2-5, the vent arrangement 1076 is provided to the frame and includes a plurality of holes 1077 (e.g., 5-100 holes, e.g., 20-50 holes, or about 35 holes) oriented at an angle (e.g., 45°) on the outer surface of the frame so as ensure the exhausted air is directed away from the patient and preferably their bed partner when the patient is sleeping. As shown in FIGS. 1C and 1D, each hole 1077 may include a contour or taper along its length. However, it should be appreciated that the vent arrangement may include other suitable arrangements, e.g., different number of holes, hole arrangement, positioning on frame, vent provides part pf interlocking structure with shroud, etc.



FIG. 35-1 illustrates a vent arrangement 276 provided to the frame 240 for gas washout. In the illustrated embodiment, the vent arrangement 276 is in the form of a vent insert (e.g., elastomeric vent insert) that is adapted to be removably supported within an outlet opening in the frame 240. The vent insert may be similar those described in U.S. Pat. Nos. 6,561,190, 6,561,191, and 7,207,335, each of which is incorporated herein by reference in its entirety. However, it should be appreciated that the vent arrangement may have other suitable forms (e.g., vent holes in main body, etc.).



FIGS. 37-3, 39-2, and 39-4 illustrate a frame 340 that includes a u-shaped slot 302 that receives a u-shaped plug-type vent 305 for gas washout. As illustrated, the plug-type vent 305 wraps around and under the opening in the frame 340 for the elbow 370. The plug-type vent 305 includes a plurality of tracks or grooves 307 on each side thereof. In use, the grooved plug-type vent 305 forms a seal with the slot 302 so that exhausted air can exit between the slot walls and the grooves 307 on the plug-type vent 305. In an embodiment, the port caps 347 may be integrated or incorporated into the plug-type vent 305 (e.g., integrally formed in one piece). Further details of such a plug-type vent arrangement are provided in U.S. patent application Ser. No. 12/230,120, filed Aug. 22, 2008, which is incorporated herein by reference in its entirety. FIGS. 39-2 to 39-6 show the frame 340 with the grooved plug-type vent 305 removed so as to more clearly illustrate the u-shaped slot 302 and auxiliary ports 343 on each side thereof.


Also, it should be appreciated that the vent arrangement may be provided to the elbow. For example, as shown in FIGS. 27-30, the vent arrangement 76 is in the form of a vent insert that is adapted to be removably supported within an outlet opening in the elbow 70. In an embodiment, the vent arrangement 76 includes a base adapted to be supported within the outlet opening, one or more grill components or media (e.g., filter, membrane, or other porous material) provided to the base and structured to diffuse vent flow, and a cover to maintain the grill components/media within the base. Only the cover 77 of the vent arrangement 76 is visible in FIGS. 27-30.


Exemplary embodiments of such a vent arrangement are disclosed in U.S. patent application Ser. No. 12/230,120, filed Aug. 22, 2008, which is incorporated herein by reference in its entirety.


However, it should be appreciated that the vent arrangement may include other suitable arrangements, e.g., vent insert with one or more vent holes.


Also, the elbow may provide an alternative venting arrangement to the vent insert. For example, as indicated in dashed lines in FIG. 30, the first end portion 74(1) of the elbow 70 (e.g., along the interfacing structure 75) may include one or more vent holes 276 for gas washout. The one or more holes 276 may be provided to a soft part (e.g., silicone seal as described below) and/or a hard part (e.g., polycarbonate, polypropylene) of the elbow. The holes 276 may extend around the entire perimeter of the first end portion 74(1) or may extend along one or more portions of the first end portion 74(1). It is noted that providing vent holes along the entire perimeter of the elbow may help to disperse the vent flow in use. However, other suitable hole arrangements, hole numbers, and/or hole shapes along the first end portion 74(1) and/or other portions of the elbow are possible.


5.4 Ports


In FIGS. 1-5, the base of the frame 1040 includes two ports 1043 positioned so that in use, oxygen or other breathable gas can be delivered close to the patient's nares or pressure monitoring equipment can be attached. The ports 1043 may also be used to attach additional medical equipment such as pressure or flow sensors. The ports may be selectively closable or sealable by a ports cap.


In an alternative embodiment, as shown in FIGS. 25 and 26, the frame 1040 may include a side port 1043.1, e.g., in addition to or as an alternative to the ports 1043.



FIGS. 35-1 and 35-2 show a frame 240 that includes an auxiliary port or spigot 243 on an upper portion of the frame, e.g., for supplemental oxygen, measurement device, etc.


In FIGS. 37-1 to 37-3 and 39-1 to 39-6, the frame 340 includes an auxiliary port or spigot 343 on each side thereof, e.g., for supplemental oxygen, measurement device, etc. Port caps 347 are provided to seal respective ports 343.


6. Interface Seal


In an embodiment, a seal may be provided at the interface between the elbow and the shroud, at the interface between the frame and the shroud, and/or at the interface between the elbow and the frame. For example, a seal (e.g., elastomeric, ring-shaped seal) may be formed separately from the modules and attached at the interface (e.g., sandwiched between modules, adhesive, etc.). Alternatively, a seal may be co-molded with one or more of the modules. In an embodiment, a silicone lip seal may be provided to the frame to seal against the elbow, thereby reducing leak.


In another embodiment, as shown in FIG. 27-30, the interfacing structure 75 of the elbow 70 may be constructed of a relatively soft, sealing material (e.g., silicone, which may be co-molded to the harder material of the elbow) that is structured to provide a seal at the interface between the elbow 70 and the shroud 20. Also, the relatively soft interfacing structure 75 (e.g., silicone) provides a “soft” attachment to the relatively hard shroud 20 (e.g., polycarbonate, polypropylene) which may allow an interference type fit. As noted above, one or more vent holes may be provided to the softer interfacing structure and/or the harder elbow.


While the invention has been described in connection with what are presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention. Also, the various embodiments described above may be implemented in conjunction with other embodiments, e.g., aspects of one embodiment may be combined with aspects of another embodiment to realize yet other embodiments. Further, each independent feature or component of any given assembly may constitute an additional embodiment. Furthermore, each individual component of any given assembly, one or more portions of an individual component of any given assembly, and various combinations of components from one or more embodiments may include one or more ornamental design features. In addition, while the invention has particular application to patients who suffer from OSA, it is to be appreciated that patients who suffer from other illnesses (e.g., congestive heart failure, diabetes, morbid obesity, stroke, bariatric surgery, etc.) can derive benefit from the above teachings. Moreover, the above teachings have applicability with patients and non-patients alike in non-medical applications.

Claims
  • 1. A mask assembly for treating a patient with a respiratory disorder, comprising: a cushion module at least partly forming a breathing chamber when the cushion module contacts the patient's face in use, the cushion module having a frame and a cushion, the frame being more rigid than the cushion and the cushion being configured to form a seal with a patient's face in use, the frame having a frame opening;headgear configured to hold the cushion module in a sealing position in order to enable a supply of breathable gas at positive pressure to be delivered to the patient's airways, the headgear including a pair of upper strap portions configured to engage the patient's head superior to the patient's ears and a pair of lower strap portions configured to engage the patient's head below the patient's ears,a shroud module constructed from a material more rigid than the cushion, the shroud module including a pair of lower headgear connector portions configured to connect to the pair of lower straps portions and an opening configured to align with the frame opening during use;a clip-on upper headgear connector, the clip-on upper headgear connector including a pair of arms each including a slot to receive one of the upper strap portions and a connecting portion that connects the pair of arms to one another, the connecting portion including a clip structure on each of a left and right side of said connecting portion; andan elbow-shaped conduit constructed from a more rigid material than the cushion, the elbow-shaped conduit including a first end removably snap-fit to the frame at the frame opening and a second end having a tube configured to connect to an air delivery tube to deliver pressurized breathable gas to the patient, wherein the elbow-shaped conduit redirects a flow of air from a first direction to a second direction that is angled relative to the first direction, wherein the elbow-shaped conduit includes an anti-asphyxia valve between the first end and the second end,wherein the mask assembly does not include a forehead support.
  • 2. A mask assembly for treating a patient with a breathing disorder, comprising: a cushion module at least partly forming a breathing chamber when the cushion module contacts the patient's face in use, the cushion module including a cushion and a frame with a frame opening, the frame having a collar positioned about the frame opening, the frame being more rigid than the cushion and the cushion being configured to engage a portion of the patient's face and seal with the patient's airways in use;a shroud comprising an anterior side and a posterior side opposite to the anterior side, the posterior side covering at least a part of the cushion module when the shroud and the cushion module are connected, the shroud including at least a pair of snaps fingers extending from the posterior side, each snap finger being releasably snap fit to the collar when the cushion module and the shroud are assembled; andheadgear configured to hold the cushion module in a sealing position in order to enable a supply of breathable gas at positive pressure to be delivered to the patient's airways, the headgear including a pair of strap portions configured to contact the patient's head superior to the patient's ears,a clip-on upper headgear connector comprising a pair of headgear connector portions each having a slot, each said strap portion being configured to removably connect directly to the slot of one of the headgear connector portions, and a connecting portion that connects the pair of headgear connector portions to one another, the connecting portion include a clip on each of a left and right side of said connecting portion,wherein the shroud is constructed from a more rigid material than the cushion, andwherein the mask assembly does not include a forehead support.
  • 3. The mask assembly of claim 2, further comprising a rotatable elbow engaged with the shroud.
  • 4. The mask assembly of claim 3, wherein the frame opening is circular in shape, and wherein the elbow is configured to rotate 360° with respect to the cushion module and the shroud in use, wherein the elbow has a distal end that protrudes into the frame opening.
  • 5. The mask assembly of claim 2, wherein each said headgear connector portion includes an arm and the slot is positioned at a free end of the arm, each said arm being a stiffened member that includes an upwardly curved shape, each of the stiffened members is made of a material that resists up and down movement of the stiffened members, yet allows the respective stiffened member to flexibly bend about the patient's face.
  • 6. The mask assembly of claim 2, wherein each said headgear connector portion includes an elongated arm extending from the shroud and the slot at a free end of the elongated arm, each said elongated arm is a stiffened member that includes an upwardly curved shape and is configured to avoid covering the patient's field of vision, each of the stiffened members is made of a material that resists up and down movement of the stiffened member, yet allows the stiffened member to flexibly contact the patient's face and to follow contours of the patient's face along the patient's cheek.
  • 7. The mask assembly of claim 2, further comprising an anti-asphyxia valve configured to allow the patient to breath from ambient when pressurized air is not supplied to the patient.
  • 8. A mask system comprising: a cushion module comprising: a cushion constructed of a flexible material to form a seal with a patient's nose and mouth in use, anda frame connected to the cushion and forming a breathing chamber, the frame constructed of a more rigid material than the cushion, and the frame including a frame opening configured to in-use allow a flow of breathable gas into the breathing chamber;a clip-on upper headgear connector having: a pair of arms, each of said pair of arms having a free end with a slot;a central connecting portion formed between and in one piece with the pair of arms; anda pair of clip structures, the central connecting portion being provided between the pair of clip structures, each said arm of the pair of arms extending laterally away from a respective clip structure and the connecting portion;a shroud module constructed from a more rigid material than the cushion and including a shroud opening, and the shroud module including a pair of lower headgear connectors;headgear for holding the cushion module in a sealing position in order to enable the supply of air at positive pressure to be delivered to the patient's airways, the headgear including: a pair of upper straps adapted to contact the patient's face superior to the patient's ears, each upper strap of the pair of upper straps adapted to removably connect to one of the slots, anda pair of lower straps adapted to contact the patient's face inferior to the patient's ears, the pair of lower straps removably connected to the pair of lower headgear connectors via a pair of headgear clips; andthe shroud opening configured to allow the cushion module to be connected to an air delivery tube to deliver breathable gas through the shroud opening and to the cushion module for breathing by the patient,wherein the mask system does not include a forehead support.
  • 9. The mask system of claim 8, wherein the cushion is a full-face cushion adapted to seal with the airways of the patient's nose and mouth, and further comprising an anti-asphyxia valve including a flap portion and a port, the flap portion being configured to close the port depending on a presence of pressurized gas.
  • 10. The mask system of claim 8, wherein a width of the upper headgear connector at each said clip structure is greater than a width of the upper headgear connector at the central connecting portion.
  • 11. The mask system of claim 10, wherein a width of the upper headgear connector along its entire length is greater than a thickness of the upper headgear connector.
  • 12. The mask system of claim 8, further comprising a pair of retaining portions to which the pair of clip structures are removably clipped.
  • 13. The mask system of claim 12, wherein each clip structure is configured to resiliently deflect when engaging with the respective retaining portion.
  • 14. The mask system of claim 12, wherein each retaining portion is configured to resiliently deflect when engaging with the respective clip structure.
  • 15. The mask system of claim 13, wherein each said clip structure includes a shoulder that releasably interlocks with the respective retaining portion.
  • 16. The mask system of claim 13, wherein the upper headgear connector is attached by moving the pair of clip structures in an anterior-posterior direction relative to the retaining portions.
  • 17. The mask system of claim 13, wherein the central connecting portion is curved within a plane extending approximately in an anterior-posterior direction.
  • 18. The mask system of claim 8, wherein an upper edge of the upper headgear connector is approximately U-shaped, such that the slots are positioned superior to the central connecting portion.
  • 19. The mask system of claim 12, further comprising a positioning member located between the pair of retaining portions.
  • 20. The mask system of claim 19, wherein the positioning member includes a guide that engages an upper edge of the upper headgear connector when the upper headgear connector is connected to the cushion module.
  • 21. The mask system of claim 20, wherein the guide has an approximate U-shape that matches the approximate U-shape of the upper edge of the upper headgear connector.
  • 22. The mask system of claim 8, wherein each upper strap of the pair of upper straps includes a hook and loop material, and each lower strap of the pair of lower straps includes a hook and loop material.
  • 23. The mask system of claim 8, wherein the headgear further includes a pair of rear straps configured to pass behind the patient's head.
  • 24. The mask system of claim 8, wherein each arm is semi-rigid and resists bending in an up or down direction.
  • 25. The mask system of claim 8, wherein each arm extends at an angle between about 10-25° with respect to horizontal.
  • 26. A device for treating sleep disorder breathing, the device comprising: the mask system of claim 8;the air delivery tube connected to the second end; anda flow generator for delivering pressurized breathable gas to the patient wearing the mask via the air delivery tube, the flow generator being adapted to deliver the pressurized breathable gas to the patient's airways at about 2-30 cm H2O above atmospheric pressure.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 17/847,344, filed Jun. 23, 2022, now allowed, which is a continuation of U.S. patent application Ser. No. 17/361,420, filed Jun. 29, 2021, which is a continuation of U.S. patent application Ser. No. 15/964,887, filed Apr. 27, 2018, now U.S. Pat. No. 11,077,274, which is a continuation of U.S. patent application Ser. No. 15/724,732, filed Oct. 4, 2017, now U.S. Pat. No. 9,962,511, which is a continuation of U.S. patent application Ser. No. 15/682,117, filed Aug. 21, 2017, now U.S. Pat. No. 9,950,131, which is a continuation of U.S. patent application Ser. No. 15/440,972, filed Feb. 23, 2017, now U.S. Pat. No. 9,770,568, which is a continuation of U.S. patent application Ser. No. 13/964,280, filed Aug. 12, 2013, now U.S. Pat. No. 9,757,533, which is a continuation of U.S. application Ser. No. 13/745,077, now U.S. Pat. No. 8,528,561, filed on Jan. 18, 2013, which is a continuation of U.S. application Ser. No. 12/736,024, now U.S. Pat. No. 8,550,084, filed on Sep. 2, 2010, which is the U.S. National Stage of PCT/AU2009/000241, filed Feb. 27, 2009, which claims benefit to U.S. Provisional Application Nos. 61/064,406, filed Mar. 4, 2008, 61/071,893, filed May 23, 2008, and 61/136,617, filed Sep. 19, 2008, each of which is incorporated herein by reference in its entirety.

US Referenced Citations (905)
Number Name Date Kind
364394 Bright Jun 1887 A
428592 Chapman May 1890 A
433418 Nutz Jul 1890 A
443191 Illing Dec 1890 A
781516 Guthrie, Jr. Jan 1905 A
812706 Warbasse Feb 1906 A
1081745 Johnston et al. Dec 1913 A
1125542 Humphries Jan 1915 A
1176886 Ermold Mar 1916 A
1192186 Greene Jul 1916 A
1206045 Smith Nov 1916 A
1229050 Donald Jun 1917 A
1282527 Bidonde Oct 1918 A
1362766 McGargill Dec 1920 A
1445010 Feinberg Feb 1923 A
1502450 Wood Jul 1924 A
1610793 Kaufman Dec 1926 A
1632449 McKesson Jun 1927 A
1653572 Jackson Dec 1927 A
1710160 Gibbs Apr 1929 A
1837591 Shindel Dec 1931 A
1873160 Sturtevant Aug 1932 A
1926027 Biggs Sep 1933 A
2011733 Shindel Aug 1935 A
2016212 O'Connell Oct 1935 A
2104016 Biggs Jan 1938 A
2123353 Catt Jul 1938 A
2127136 Pobirs Aug 1938 A
2130555 Malcom Sep 1938 A
2133699 Heidbrink Oct 1938 A
2149067 Otero Feb 1939 A
2166164 Lehmberg Jul 1939 A
2245658 Erickson Jun 1941 A
2245969 Francisco et al. Jun 1941 A
2248477 Lombard Jul 1941 A
2254854 O'Connell Sep 1941 A
2317608 Heidbrink Apr 1943 A
2353643 Bulbulian Jul 1944 A
2371965 Lehmberg Mar 1945 A
2376871 Fink May 1945 A
2382364 Yant Aug 1945 A
2415846 Randall Feb 1947 A
2428451 Emerson Oct 1947 A
2433565 Korman Dec 1947 A
2438058 Kincheloe Mar 1948 A
2473518 Garrard et al. Jun 1949 A
D156060 Wade Nov 1949 S
D161337 Hill Dec 1950 S
2540567 Bennett Feb 1951 A
2578621 Yant Dec 1951 A
2590006 Gordon Mar 1952 A
2625155 Engelder Jan 1953 A
2641253 Engelder Jun 1953 A
2693178 Gilroy Nov 1954 A
2706983 Matheson et al. Apr 1955 A
2749910 Faulconer, Jr. Jun 1956 A
RE24193 Emerson Aug 1956 E
2820651 Phillips Jan 1958 A
2827900 Marietta Mar 1958 A
2837090 Bloom et al. Jun 1958 A
2868196 Stampe Jan 1959 A
2875757 Galleher, Jr. Mar 1959 A
2875759 Galleher, Jr. Mar 1959 A
2881444 Fresh et al. Apr 1959 A
2882895 Galeazzi Apr 1959 A
2902033 Galleher, Jr. Sep 1959 A
2917045 Schildknecht et al. Dec 1959 A
2931356 Schwarz Apr 1960 A
D188084 Garelick May 1960 S
2939458 Lundquist Jun 1960 A
2966917 Bloom Jan 1961 A
3013556 Galleher, Jr. Dec 1961 A
3042035 Coanda Jul 1962 A
3117574 Replogle Jan 1964 A
3182659 Blount May 1965 A
3189027 Bartlett, Jr. Jun 1965 A
3193624 Webb et al. Jul 1965 A
3238943 Holley Mar 1966 A
3288138 Sachs Nov 1966 A
3315672 Cunningham et al. Apr 1967 A
3315674 Bloom et al. Apr 1967 A
3330273 Bennett Jul 1967 A
3330274 Bennett Jul 1967 A
3362420 Blackburn et al. Jan 1968 A
3363833 Laerdal Jan 1968 A
3545436 Holloway Dec 1970 A
3556122 Laerdal Jan 1971 A
3580051 Blevins May 1971 A
3670726 Mahon et al. Mar 1972 A
3682171 Dali et al. Aug 1972 A
3700000 Hesse et al. Oct 1972 A
3720235 Schrock Mar 1973 A
3725953 Johnson et al. Apr 1973 A
3739774 Gregory Jun 1973 A
3750333 Vance Aug 1973 A
3752157 Malmin Aug 1973 A
3754552 King Aug 1973 A
3796216 Schwarz Mar 1974 A
3799164 Rollins Mar 1974 A
D231803 Huddy Jun 1974 S
3830230 Chester Aug 1974 A
3861385 Carden Jan 1975 A
3902486 Guichard Sep 1975 A
3905361 Hewson et al. Sep 1975 A
3910261 Ragsdale et al. Oct 1975 A
3938614 Ahs Feb 1976 A
3972321 Proctor Aug 1976 A
3978854 Mills, Jr. Sep 1976 A
4006744 Steer Feb 1977 A
4007737 Paluch Feb 1977 A
4062357 Laerdal Dec 1977 A
4069516 Watkins, Jr. Jan 1978 A
4077404 Elam Mar 1978 A
D248497 Slosek Jul 1978 S
D250131 Lewis et al. Oct 1978 S
4120302 Ziegler Oct 1978 A
4142527 Garcia Mar 1979 A
4153051 Shippert May 1979 A
4156426 Gold May 1979 A
4167185 Lewis Sep 1979 A
4201205 Bartholomew May 1980 A
4226234 Gunderson Oct 1980 A
4231363 Grimes Nov 1980 A
4233972 Hauff et al. Nov 1980 A
4239038 Holmes Dec 1980 A
4245632 Houston Jan 1981 A
4248218 Fischer Feb 1981 A
4263908 Mizerak Apr 1981 A
4264743 Maruyama et al. Apr 1981 A
4265239 Fischer, Jr. et al. May 1981 A
4266540 Panzik et al. May 1981 A
4267845 Robertson, Jr. et al. May 1981 A
4273124 Zimmerman Jun 1981 A
4274406 Bartholomew Jun 1981 A
D262322 Mizerak Dec 1981 S
4304229 Curtin Dec 1981 A
4312359 Olson Jan 1982 A
4328797 Rollins et al. May 1982 A
4337767 Yahata Jul 1982 A
4347205 Stewart Aug 1982 A
4354488 Bartos Oct 1982 A
4367735 Dali Jan 1983 A
4367816 Wilkes Jan 1983 A
4369284 Chen Jan 1983 A
4402316 Gadberry Sep 1983 A
4406283 Bir Sep 1983 A
4412537 Tiger Nov 1983 A
4414973 Matheson et al. Nov 1983 A
4417575 Hilton et al. Nov 1983 A
4422456 Teip Dec 1983 A
4446576 Hisataka May 1984 A
4449526 Elam May 1984 A
4454880 Muto et al. Jun 1984 A
4454881 Huber et al. Jun 1984 A
4455675 Bose et al. Jun 1984 A
4458679 Ward Jul 1984 A
4467799 Steinberg Aug 1984 A
4493614 Chu et al. Jan 1985 A
4522639 Ansite et al. Jun 1985 A
4548200 Wapner Oct 1985 A
4549542 Chein Nov 1985 A
4558710 Eichler Dec 1985 A
4572323 Randall Feb 1986 A
4579113 McCreadie et al. Apr 1986 A
4587967 Chu et al. May 1986 A
4593688 Payton Jun 1986 A
4601465 Roy Jul 1986 A
4603692 Montesi Aug 1986 A
D285496 Berman Sep 1986 S
4616647 McCreadie Oct 1986 A
4617637 Chu et al. Nov 1986 A
4622964 Flynn Nov 1986 A
4630604 Montesi Dec 1986 A
4641645 Tayebi Feb 1987 A
4641647 Behan Feb 1987 A
D289238 Arthur, Jr. Apr 1987 S
4655213 Rapoport et al. Apr 1987 A
4657010 Wright Apr 1987 A
4660555 Payton Apr 1987 A
4665570 Davis May 1987 A
4671267 Stout Jun 1987 A
4671271 Bishop et al. Jun 1987 A
4674134 Lundin Jun 1987 A
4676241 Webb et al. Jun 1987 A
4677975 Edgar et al. Jul 1987 A
4677977 Wilcox Jul 1987 A
4686977 Cosma Aug 1987 A
4699139 Marshall et al. Oct 1987 A
4706664 Snook et al. Nov 1987 A
4707863 McNeal Nov 1987 A
4711636 Bierman Dec 1987 A
4713844 Westgate Dec 1987 A
H397 Stark Jan 1988 H
D293613 Wingler Jan 1988 S
4739755 White et al. Apr 1988 A
4753233 Grimes Jun 1988 A
4767411 Edmunds Aug 1988 A
4770169 Schmoegner et al. Sep 1988 A
4772760 Graham Sep 1988 A
4774941 Cook Oct 1988 A
4774946 Ackerman et al. Nov 1988 A
4782832 Trimble et al. Nov 1988 A
4790829 Bowden et al. Dec 1988 A
4799477 Lewis Jan 1989 A
4802857 Laughlin Feb 1989 A
4803981 Vickery Feb 1989 A
4807617 Nesti Feb 1989 A
4809692 Nowacki et al. Mar 1989 A
4811730 Milano Mar 1989 A
4819629 Jonson Apr 1989 A
4821713 Bauman Apr 1989 A
4827924 Japuntich May 1989 A
4830138 Palmaer et al. May 1989 A
4832017 Schnoor May 1989 A
4838878 Kalt et al. Jun 1989 A
4841953 Dodrill Jun 1989 A
4848334 Bellm Jul 1989 A
4848366 Aita et al. Jul 1989 A
4850346 Michel et al. Jul 1989 A
4856118 Sapiejewski Aug 1989 A
D304384 Derobert Oct 1989 S
4886058 Bromstrom et al. Dec 1989 A
4899740 Napolitano Feb 1990 A
4905683 Cronjaeger Mar 1990 A
4907584 McGinnis Mar 1990 A
4910806 Baker et al. Mar 1990 A
4914957 Dougherty Apr 1990 A
4915105 Lee Apr 1990 A
4915106 Aulgur et al. Apr 1990 A
4919128 Kopala et al. Apr 1990 A
4919654 Kalt Apr 1990 A
4938210 Shene Jul 1990 A
4938212 Snook et al. Jul 1990 A
4941476 Fisher Jul 1990 A
4944310 Sullivan Jul 1990 A
4945907 Tayebi Aug 1990 A
4947860 Fisher Aug 1990 A
D310431 Bellm Sep 1990 S
4960121 Nelson et al. Oct 1990 A
4966590 Kalt Oct 1990 A
4969880 Zamierowski Nov 1990 A
4971051 Toffolon Nov 1990 A
D313277 Haining Dec 1990 S
4976698 Stokley Dec 1990 A
4986269 Hakkinen Jan 1991 A
4989271 Sapiejewski et al. Feb 1991 A
4989596 Macris et al. Feb 1991 A
4989599 Carter Feb 1991 A
4996983 AmRhein Mar 1991 A
5000173 Zalkin et al. Mar 1991 A
5003631 Richardson Apr 1991 A
5003633 Itoh Apr 1991 A
5005568 Loescher et al. Apr 1991 A
5005571 Dietz Apr 1991 A
5018519 Brown May 1991 A
5020163 Aileo et al. Jun 1991 A
5022900 Bar-Yona et al. Jun 1991 A
5023955 Murphy, II et al. Jun 1991 A
5025805 Nutter Jun 1991 A
5027809 Robinson Jul 1991 A
5038772 Kolbe et al. Aug 1991 A
5038776 Harrison et al. Aug 1991 A
5042473 Lewis Aug 1991 A
5042478 Kopala et al. Aug 1991 A
5046200 Feder Sep 1991 A
5046491 Derrick Sep 1991 A
5062421 Burns et al. Nov 1991 A
5063922 Hakkinen Nov 1991 A
5069205 Urso Dec 1991 A
5074297 Venegas Dec 1991 A
5080092 Tenna Jan 1992 A
D323908 Hollister et al. Feb 1992 S
5093940 Nishiyama Mar 1992 A
5109839 Blasdell et al. May 1992 A
5109840 Daleiden May 1992 A
5113857 Dickerman et al. May 1992 A
5117818 Palfy Jun 1992 A
5121745 Israel Jun 1992 A
5121746 Sikora Jun 1992 A
5123677 Kreczko et al. Jun 1992 A
5127397 Kohnke Jul 1992 A
5133347 Huennebeck Jul 1992 A
5137017 Salter Aug 1992 A
5138722 Urella et al. Aug 1992 A
5140980 Haughey et al. Aug 1992 A
5140982 Bauman Aug 1992 A
5146914 Sturrock Sep 1992 A
5159938 Laughlin Nov 1992 A
5178138 Walstrom et al. Jan 1993 A
5181506 Tardiff, Jr. et al. Jan 1993 A
D333015 Farmer et al. Feb 1993 S
5188101 Tumolo Feb 1993 A
D334633 Rudolph Apr 1993 S
5199424 Sullivan et al. Apr 1993 A
D335322 Jones May 1993 S
5207665 Davis et al. May 1993 A
5220699 Farris Jun 1993 A
5222478 Scarberry et al. Jun 1993 A
5231983 Matson et al. Aug 1993 A
5233978 Callaway Aug 1993 A
5243709 Sheehan et al. Sep 1993 A
5243971 Sullivan et al. Sep 1993 A
5245995 Sullivan et al. Sep 1993 A
5263939 Wortrich Nov 1993 A
5265592 Beaussant Nov 1993 A
5265595 Rudolph Nov 1993 A
5267557 Her-Mou Dec 1993 A
5269296 Landis Dec 1993 A
5271391 Graves Dec 1993 A
5279289 Kirk Jan 1994 A
5280784 Kohler Jan 1994 A
5291880 Almovist et al. Mar 1994 A
5299448 Maryyanek Apr 1994 A
5299579 Gedeon et al. Apr 1994 A
5299599 Farmer et al. Apr 1994 A
5301689 Wennerholm Apr 1994 A
5304146 Johnson et al. Apr 1994 A
5311862 Blasdell et al. May 1994 A
5322057 Raabe et al. Jun 1994 A
5322059 Walther Jun 1994 A
5331691 Runckel Jul 1994 A
D349586 Handke Aug 1994 S
5334646 Chen Aug 1994 A
5335656 Bowe et al. Aug 1994 A
5343878 Scarberry et al. Sep 1994 A
5349949 Schegerin Sep 1994 A
5353789 Schlobohm Oct 1994 A
5355878 Griffiths et al. Oct 1994 A
5355893 Mick et al. Oct 1994 A
5357945 Messina Oct 1994 A
5357951 Ratner Oct 1994 A
5364367 Banks et al. Nov 1994 A
5372130 Stern et al. Dec 1994 A
5372388 Gargiulo Dec 1994 A
5372389 Tam et al. Dec 1994 A
5372390 Conway et al. Dec 1994 A
5372391 Bast et al. Dec 1994 A
5375593 Press Dec 1994 A
5385141 Granatiero Jan 1995 A
5388571 Roberts et al. Feb 1995 A
5390373 Flory Feb 1995 A
5391248 Brain Feb 1995 A
5394568 Brostrom et al. Mar 1995 A
5396885 Nelson Mar 1995 A
5398676 Press et al. Mar 1995 A
5400776 Bartholomew Mar 1995 A
5400781 Davenport Mar 1995 A
5404871 Goodman et al. Apr 1995 A
5419317 Blasdell et al. May 1995 A
5419318 Tayebi May 1995 A
5425359 Liou Jun 1995 A
5429126 Bracken Jul 1995 A
5429683 Le Mitouard Jul 1995 A
5431158 Tirotta Jul 1995 A
5437267 Weinstein et al. Aug 1995 A
5438981 Starr et al. Aug 1995 A
5441046 Starr et al. Aug 1995 A
D362061 McGinnis et al. Sep 1995 S
5462528 Roewer Oct 1995 A
5477852 Landis et al. Dec 1995 A
5479920 Piper et al. Jan 1996 A
5481763 Brostrom et al. Jan 1996 A
5485837 Bee et al. Jan 1996 A
5488948 Dubruille et al. Feb 1996 A
5492116 Scarberry et al. Feb 1996 A
5501214 Sabo Mar 1996 A
5503147 Bertheau Apr 1996 A
5509404 Lloyd et al. Apr 1996 A
5509409 Weatherholt Apr 1996 A
5511541 Dearstine Apr 1996 A
5513634 Jackson May 1996 A
5513635 Bedi May 1996 A
5517986 Starr et al. May 1996 A
5522382 Sullivan et al. Jun 1996 A
5526806 Sansoni Jun 1996 A
5533506 Wood Jul 1996 A
5538000 Rudolph Jul 1996 A
5538001 Bridges Jul 1996 A
5540223 Starr et al. Jul 1996 A
5542128 Lomas Aug 1996 A
5546936 Virag et al. Aug 1996 A
5558090 James Sep 1996 A
RE35339 Rapoport Oct 1996 E
5560354 Berthon-Jones et al. Oct 1996 A
5568946 Jackowski Oct 1996 A
5570682 Johnson Nov 1996 A
5570684 Behr Nov 1996 A
5570689 Starr et al. Nov 1996 A
5575278 Bonhomme et al. Nov 1996 A
D377089 Starr et al. Dec 1996 S
5592937 Freund Jan 1997 A
5592938 Scarberry et al. Jan 1997 A
5608647 Rubsamen et al. Mar 1997 A
5617849 Springett et al. Apr 1997 A
5623923 Bertheau et al. Apr 1997 A
5642726 Owens et al. Jul 1997 A
5642730 Baran Jul 1997 A
5645054 Cotner et al. Jul 1997 A
5647355 Starr et al. Jul 1997 A
5647356 Barnett et al. Jul 1997 A
5647357 Barnett et al. Jul 1997 A
5649532 Griffiths Jul 1997 A
5649533 Oren Jul 1997 A
5653228 Byrd Aug 1997 A
5655520 Howe et al. Aug 1997 A
5655527 Scarberry et al. Aug 1997 A
5657493 Ferrero et al. Aug 1997 A
5657752 Landis et al. Aug 1997 A
5660171 Kimm et al. Aug 1997 A
5660174 Jacobelli Aug 1997 A
5662101 Ogden et al. Sep 1997 A
5666946 Langenback Sep 1997 A
5676133 Hickle et al. Oct 1997 A
D385960 Rudolph Nov 1997 S
5682881 Winthrop et al. Nov 1997 A
5685296 Zdrojkowski et al. Nov 1997 A
5687715 Landis et al. Nov 1997 A
D389238 Kirk, III et al. Jan 1998 S
5704345 Berthon-Jones Jan 1998 A
5707342 Tanaka Jan 1998 A
5709204 Lester Jan 1998 A
5715814 Ebers Feb 1998 A
5724964 Brunson et al. Mar 1998 A
5724965 Handke et al. Mar 1998 A
5732695 Metzger Mar 1998 A
5735272 Dillon et al. Apr 1998 A
5740799 Nielson Apr 1998 A
5746201 Kidd May 1998 A
5752509 Lachmann et al. May 1998 A
5752511 Simmons et al. May 1998 A
5771886 Maire et al. Jun 1998 A
5778872 Fukunaga et al. Jul 1998 A
5782774 Shmulewitz Jul 1998 A
5794615 Estes Aug 1998 A
5794617 Brunell et al. Aug 1998 A
5794619 Edeiman et al. Aug 1998 A
D398987 Cotner et al. Sep 1998 S
5807341 Heim Sep 1998 A
5813423 Kirchgeorg Sep 1998 A
5832918 Pantino Nov 1998 A
D402755 Kwok Dec 1998 S
5842469 Rapp et al. Dec 1998 A
RE36165 Behr Mar 1999 E
5884624 Barnett et al. Mar 1999 A
5887587 Groenke Mar 1999 A
5896857 Hely et al. Apr 1999 A
5906203 Klockseth et al. May 1999 A
5909732 Diesel et al. Jun 1999 A
5918598 Belfer et al. Jul 1999 A
5921239 McCall et al. Jul 1999 A
D412745 Scheu Aug 1999 S
5935136 Hulse et al. Aug 1999 A
5937445 Ravo et al. Aug 1999 A
5937851 Serowski et al. Aug 1999 A
5954049 Foley et al. Sep 1999 A
5964485 Hame et al. Oct 1999 A
5966745 Schwartz et al. Oct 1999 A
5970975 Estes et al. Oct 1999 A
5975079 Hellings et al. Nov 1999 A
6003511 Fukunaga et al. Dec 1999 A
6006748 Hollis Dec 1999 A
D419658 Matchett et al. Jan 2000 S
6016804 Gleason et al. Jan 2000 A
D421298 Kenyon et al. Feb 2000 S
6019101 Cotner et al. Feb 2000 A
6026811 Settle Feb 2000 A
6029660 Calluaud et al. Feb 2000 A
6029665 Berthon-Jones Feb 2000 A
6039044 Sullivan Mar 2000 A
D423096 Kwok Apr 2000 S
6044844 Kwok et al. Apr 2000 A
6062221 Brostrom May 2000 A
6082360 Rudolph et al. Jul 2000 A
6086118 McNaughton et al. Jul 2000 A
6091973 Colla et al. Jul 2000 A
D428987 Kwok Aug 2000 S
6095996 Steer et al. Aug 2000 A
6102040 Tayebi et al. Aug 2000 A
6109263 Feuchtgruber Aug 2000 A
6112746 Kwok et al. Sep 2000 A
6119693 Kwok et al. Sep 2000 A
6119694 Correa et al. Sep 2000 A
6123071 Berthon-Jones et al. Sep 2000 A
6123082 Berthon-Jones Sep 2000 A
6139787 Harrison Oct 2000 A
6152137 Schwartz et al. Nov 2000 A
6155253 Gamberini Dec 2000 A
6192886 Rudolph Feb 2001 B1
6193914 Harrison Feb 2001 B1
D439326 Hecker et al. Mar 2001 S
6196223 Belfer et al. Mar 2001 B1
6211263 Cinelli et al. Apr 2001 B1
6213125 Reese et al. Apr 2001 B1
6231548 Bassett May 2001 B1
D443355 Gunaratnam et al. Jun 2001 S
6241930 Harrison Jun 2001 B1
6257237 Suzuki Jul 2001 B1
6257626 Campau Jul 2001 B1
6258066 Urich Jul 2001 B1
6279573 Johnson et al. Aug 2001 B1
6295366 Baller et al. Sep 2001 B1
6298849 Scholey et al. Oct 2001 B1
6328031 Tischer et al. Dec 2001 B1
6328038 Kessler et al. Dec 2001 B1
6340024 Brookman et al. Jan 2002 B1
6341606 Bordewick et al. Jan 2002 B1
6345618 Hayek Feb 2002 B1
6347631 Hansen et al. Feb 2002 B1
6357440 Hansen et al. Mar 2002 B1
6357441 Kwok et al. Mar 2002 B1
6358279 Tahi et al. Mar 2002 B1
6371110 Peterson et al. Apr 2002 B1
6374826 Gunaratnam et al. Apr 2002 B1
6388640 Chigira et al. May 2002 B1
6397847 Scarberry et al. Jun 2002 B1
6412487 Gunaratnam et al. Jul 2002 B1
6412488 Barnett et al. Jul 2002 B1
6412593 Jones Jul 2002 B1
6418928 Bordewick et al. Jul 2002 B1
6419660 Russo Jul 2002 B1
6422238 Lithgow Jul 2002 B1
6423036 Huzen Jul 2002 B1
6425395 Brewer et al. Jul 2002 B1
6427694 Hecker et al. Aug 2002 B1
6431172 Bordewick Aug 2002 B1
6434796 Speirs Aug 2002 B1
6435181 Jones, Jr. et al. Aug 2002 B1
6439230 Gunaratnam et al. Aug 2002 B1
6439234 Curti et al. Aug 2002 B1
6448303 Paul Sep 2002 B1
6457473 Brostrom et al. Oct 2002 B1
6463931 Kwok et al. Oct 2002 B1
6467482 Boussignac Oct 2002 B1
6467483 Kopacko et al. Oct 2002 B1
6470887 Martinez Oct 2002 B1
6478026 Wood Nov 2002 B1
6482178 Andrews et al. Nov 2002 B1
6491034 Gunaratnam et al. Dec 2002 B1
D468823 Smart Jan 2003 S
6513526 Kwok et al. Feb 2003 B2
6520182 Gunaratnam Feb 2003 B1
6530373 Patron et al. Mar 2003 B1
6532961 Kwok et al. Mar 2003 B1
6536435 Fecteau et al. Mar 2003 B1
6557556 Kwok et al. May 2003 B2
6561188 Ellis May 2003 B1
6561190 Kwok May 2003 B1
6561191 Kwok May 2003 B1
6561192 Palmer May 2003 B2
6561193 Noble May 2003 B1
6571798 Thornton Jun 2003 B1
6579267 Lynch et al. Jun 2003 B2
6581594 Drew Jun 2003 B1
6581601 Ziaee Jun 2003 B2
6581602 Kwok et al. Jul 2003 B2
6584975 Taylor Jul 2003 B1
6595214 Hecker et al. Jul 2003 B1
6595215 Wood Jul 2003 B2
6607516 Cinelli et al. Aug 2003 B2
6615830 Serowski et al. Sep 2003 B1
6615832 Chen Sep 2003 B1
6626177 Ziaee Sep 2003 B1
6627289 Dilnik et al. Sep 2003 B1
6631718 Lovell Oct 2003 B1
6634358 Kwok et al. Oct 2003 B2
6637434 Noble Oct 2003 B2
6644315 Ziaee Nov 2003 B2
6651663 Barnett et al. Nov 2003 B2
D484237 Lang et al. Dec 2003 S
6655385 Curti et al. Dec 2003 B1
6663600 Bierman et al. Dec 2003 B2
6669712 Cardoso Dec 2003 B1
D485905 Moore et al. Jan 2004 S
6679257 Robertson et al. Jan 2004 B1
6679261 Lithgow Jan 2004 B2
6679265 Strickland et al. Jan 2004 B2
6691707 Gunaratnam et al. Feb 2004 B1
6691708 Kwok et al. Feb 2004 B2
6701535 Dobbie et al. Mar 2004 B2
6701926 Olsen et al. Mar 2004 B2
6701927 Kwok et al. Mar 2004 B2
6710099 Cinelli et al. Mar 2004 B2
6712072 Lang Mar 2004 B1
6729333 Barnett et al. May 2004 B2
6732733 Brostrom May 2004 B1
D492992 Guney et al. Jul 2004 S
D493521 Guney Jul 2004 S
6766800 Chu et al. Jul 2004 B2
6766817 da Silva Jul 2004 B2
6772760 Frater et al. Aug 2004 B2
6776162 Wood Aug 2004 B2
6776163 Dougill et al. Aug 2004 B2
6789543 Cannon Sep 2004 B2
6796308 Gunaratnam et al. Sep 2004 B2
6805117 Ho et al. Oct 2004 B1
6807967 Wood Oct 2004 B2
6817362 Gelinas et al. Nov 2004 B2
6820617 Robertson et al. Nov 2004 B2
6823865 Drew et al. Nov 2004 B2
6823869 Raje et al. Nov 2004 B2
6834650 Fini Dec 2004 B1
6851425 Jaffre Feb 2005 B2
6851428 Dennis Feb 2005 B2
6851429 Bishop Feb 2005 B2
6860269 Kwok et al. Mar 2005 B2
6860270 Sniadich Mar 2005 B2
6871649 Kwok et al. Mar 2005 B2
6892729 Smith et al. May 2005 B2
6895965 Scarberry et al. May 2005 B2
6907882 Ging Jun 2005 B2
6914091 Donald et al. Jul 2005 B2
6918404 Dias da Silva Jul 2005 B2
6926004 Schumacher Aug 2005 B2
6938620 Payne, Jr. Sep 2005 B2
6951218 Gradon et al. Oct 2005 B2
6959710 Barnett et al. Nov 2005 B2
6968844 Liland Nov 2005 B2
6972003 Bierman et al. Dec 2005 B2
6986352 Frater et al. Jan 2006 B2
6997177 Wood Feb 2006 B2
7000614 Lang et al. Feb 2006 B2
7007696 Palkon et al. Mar 2006 B2
7011090 Drew et al. Mar 2006 B2
7018362 Bierman et al. Mar 2006 B2
7040321 Goebel May 2006 B2
7052127 Harrison May 2006 B2
7059326 Heidmann et al. Jun 2006 B2
7066179 Eaton et al. Jun 2006 B2
7066586 da Silva Jun 2006 B2
7069932 Eaton Jul 2006 B2
7076282 Munro et al. Jul 2006 B2
7076822 Pearce Jul 2006 B2
7080645 Genger et al. Jul 2006 B2
7093599 Chen Aug 2006 B2
7100610 Biener et al. Sep 2006 B2
7101359 Kline et al. Sep 2006 B2
7107989 Frater et al. Sep 2006 B2
7114497 Aylsworth et al. Oct 2006 B2
7121279 Dennis Oct 2006 B2
7146976 McKown Dec 2006 B2
7152599 Thomas Dec 2006 B2
7152601 Barakat et al. Dec 2006 B2
7178525 Matula, Jr. et al. Feb 2007 B2
7185652 Gunaratnam et al. Mar 2007 B2
7191781 Wood Mar 2007 B2
7207328 Altemus Apr 2007 B1
7207335 Kwok et al. Apr 2007 B2
7210481 Lovell et al. May 2007 B1
7216647 Lang et al. May 2007 B2
7237551 Ho et al. Jul 2007 B2
7243723 Surjaatmadja Jul 2007 B2
D550836 Chandran et al. Sep 2007 S
D552733 Criscuolo et al. Oct 2007 S
7285255 Kadlec et al. Oct 2007 B2
7302950 Berthon-Jones et al. Dec 2007 B2
7308895 Wixey et al. Dec 2007 B2
7318437 Gunaratnam Jan 2008 B2
7318439 Raje et al. Jan 2008 B2
7320323 Lang et al. Jan 2008 B2
7341060 Ging et al. Mar 2008 B2
7353826 Sleeper et al. Apr 2008 B2
7353827 Geist Apr 2008 B2
7441618 Lubke et al. Oct 2008 B2
7461656 Gunaratnam et al. Dec 2008 B2
7470256 Lampropoulos et al. Dec 2008 B2
7481220 Meyer et al. Jan 2009 B2
7487772 Ging et al. Feb 2009 B2
7503327 Gunaratnam Mar 2009 B2
7509958 Amarasinghe et al. Mar 2009 B2
7520869 Lampropoulos et al. Apr 2009 B2
7523754 Lithgow Apr 2009 B2
7562658 Madaus et al. Jul 2009 B2
7614400 Lithgow et al. Nov 2009 B2
7614401 Thompson Nov 2009 B2
7621274 Sprinkle et al. Nov 2009 B2
7624735 Ho et al. Dec 2009 B2
7640934 Zollinger et al. Jan 2010 B2
7654263 Lang et al. Feb 2010 B2
7658189 Davidson et al. Feb 2010 B2
7665464 Kopacko et al. Feb 2010 B2
7699808 Marrs et al. Apr 2010 B2
7703457 Barnett et al. Apr 2010 B2
7708017 Davidson May 2010 B2
7743767 Ging et al. Jun 2010 B2
7762259 Gunaratnam Jul 2010 B2
7775209 Biener et al. Aug 2010 B2
7779832 Ho Aug 2010 B1
7798144 Kwok et al. Sep 2010 B2
7814911 Bordewick et al. Oct 2010 B2
7819117 Park Oct 2010 B2
7819119 Ho Oct 2010 B2
7827990 Melidis Nov 2010 B1
7841345 Guney et al. Nov 2010 B2
7856980 Lang et al. Dec 2010 B2
7856982 Matula, Jr. et al. Dec 2010 B2
7861715 Jones et al. Jan 2011 B2
7874293 Gunaratnam et al. Jan 2011 B2
7878199 Ging et al. Feb 2011 B2
7900631 Persson Mar 2011 B2
7900635 Gunaratnam et al. Mar 2011 B2
7931024 Ho et al. Apr 2011 B2
7958893 Lithgow et al. Jun 2011 B2
7967013 Ging et al. Jun 2011 B2
7967014 Heidmann et al. Jun 2011 B2
7971590 Frater et al. Jul 2011 B2
7992559 Lang et al. Aug 2011 B2
7997267 Ging et al. Aug 2011 B2
8042538 Ging et al. Oct 2011 B2
8042541 Amarasinghe et al. Oct 2011 B2
8042542 Ging et al. Oct 2011 B2
8042546 Gunaratnam et al. Oct 2011 B2
8051850 Kwok et al. Nov 2011 B2
8091553 Bordewick et al. Jan 2012 B2
8096301 Smith et al. Jan 2012 B2
8136524 Ging et al. Mar 2012 B2
8136525 Lubke et al. Mar 2012 B2
8186352 Gunaratnam et al. May 2012 B2
8210180 Gunaratnam Jul 2012 B2
8220459 Davidson et al. Jul 2012 B2
8297283 Hitchcock et al. Oct 2012 B2
8397728 D'Souza et al. Mar 2013 B2
8528561 Ng et al. Sep 2013 B2
8550084 Ng et al. Oct 2013 B2
8701667 Ho Apr 2014 B1
8944061 D'Souza et al. Feb 2015 B2
9027556 Ng et al. May 2015 B2
9119931 D'Souza et al. Sep 2015 B2
9757533 Ng et al. Sep 2017 B2
9770568 Ng et al. Sep 2017 B2
9950131 Ng et al. Apr 2018 B2
9962510 Ng et al. May 2018 B2
9962511 Ng et al. May 2018 B2
11077274 Ng et al. Aug 2021 B2
11395893 Ng et al. Jul 2022 B2
20010020474 Hecker et al. Sep 2001 A1
20020005198 Kwok et al. Jan 2002 A1
20020020416 Namey Feb 2002 A1
20020023649 Gunaratnam et al. Feb 2002 A1
20020029780 Frater et al. Mar 2002 A1
20020046755 Devoss Apr 2002 A1
20020066452 Kessler et al. Jun 2002 A1
20020069872 Gradon et al. Jun 2002 A1
20020124849 Billette de Villemeur Sep 2002 A1
20020143296 Russo Oct 2002 A1
20020157673 Kessler et al. Oct 2002 A1
20020174868 Kwok et al. Nov 2002 A1
20030019495 Palkon et al. Mar 2003 A1
20030062048 Gradon et al. Apr 2003 A1
20030089373 Gradon et al. May 2003 A1
20030154984 Fernandes Aug 2003 A1
20030168063 Gambone et al. Sep 2003 A1
20030196656 Moore et al. Oct 2003 A1
20030196658 Ging et al. Oct 2003 A1
20040025882 Madaus et al. Feb 2004 A1
20040025883 Eaton et al. Feb 2004 A1
20040045550 Lang et al. Mar 2004 A1
20040065328 Amarasinghe et al. Apr 2004 A1
20040067333 Amarasinghe Apr 2004 A1
20040094157 Dantanarayana et al. May 2004 A1
20040106891 Langan et al. Jun 2004 A1
20040111104 Schein et al. Jun 2004 A1
20040112384 Lithgow et al. Jun 2004 A1
20040112385 Drew et al. Jun 2004 A1
20040118406 Lithgow et al. Jun 2004 A1
20040127856 Johnson Jul 2004 A1
20040177850 Gradon et al. Sep 2004 A1
20040182396 Dennis Sep 2004 A1
20040182398 Sprinkle et al. Sep 2004 A1
20040211428 Jones Oct 2004 A1
20040226566 Gunaratnam et al. Nov 2004 A1
20040255948 Smith Dec 2004 A1
20040255949 Lang Dec 2004 A1
20050005940 Gunaratnam Jan 2005 A1
20050011521 Sprinkle et al. Jan 2005 A1
20050011524 Thomlinson et al. Jan 2005 A1
20050022820 Kwok et al. Feb 2005 A1
20050051171 Booth Mar 2005 A1
20050051176 Riggins Mar 2005 A1
20050056286 Huddart et al. Mar 2005 A1
20050061326 Payne, Jr. Mar 2005 A1
20050072428 Ho Apr 2005 A1
20050098183 Nash et al. May 2005 A1
20050150495 Rittner et al. Jul 2005 A1
20050155604 Ging et al. Jul 2005 A1
20050199239 Lang et al. Sep 2005 A1
20050199240 Hall Sep 2005 A1
20050205096 Matula Sep 2005 A1
20050211252 Lang et al. Sep 2005 A1
20050241644 Gunaratnam et al. Nov 2005 A1
20060000476 Salem Jan 2006 A1
20060042629 Geist Mar 2006 A1
20060060200 Ho et al. Mar 2006 A1
20060076017 Walker et al. Apr 2006 A1
20060076018 Barnett et al. Apr 2006 A1
20060076019 Ho Apr 2006 A1
20060107960 Smart May 2006 A1
20060118117 Berthon-Jones Jun 2006 A1
20060124131 Chandran et al. Jun 2006 A1
20060130844 Ho Jun 2006 A1
20060137690 Gunaratnam et al. Jun 2006 A1
20060174887 Chandran Aug 2006 A1
20060201514 Jones Sep 2006 A1
20060207597 Wright Sep 2006 A1
20060213520 Frater et al. Sep 2006 A1
20060219246 Dennis Oct 2006 A1
20060231103 Matula Oct 2006 A1
20060237018 McAuley et al. Dec 2006 A1
20060272646 Ho et al. Dec 2006 A1
20060283452 Woodard et al. Dec 2006 A1
20060283456 Geiselhart Dec 2006 A1
20060283461 Lubke et al. Dec 2006 A1
20070023044 Kwok Feb 2007 A1
20070044797 Ho Mar 2007 A1
20070044804 Matula, Jr. et al. Mar 2007 A1
20070062536 McAuley Mar 2007 A1
20070137653 Wood Jun 2007 A1
20070144525 Davidson et al. Jun 2007 A1
20070163600 Hoffman Jul 2007 A1
20070193583 Reed Aug 2007 A1
20070215161 Frater et al. Sep 2007 A1
20070221226 Hansen et al. Sep 2007 A1
20070267017 McAuley et al. Nov 2007 A1
20070272249 Chandran et al. Nov 2007 A1
20070277828 Ho Dec 2007 A1
20070282272 Bannon et al. Dec 2007 A1
20080004573 Kaufmann et al. Jan 2008 A1
20080006277 Worboys et al. Jan 2008 A1
20080041391 Worley Feb 2008 A1
20080047560 Veliss et al. Feb 2008 A1
20080047561 Fu et al. Feb 2008 A1
20080060649 Veliss et al. Mar 2008 A1
20080065022 Kyvik et al. Mar 2008 A1
20080066761 Hodos et al. Mar 2008 A1
20080110464 Davidson et al. May 2008 A1
20080110469 Weinberg May 2008 A1
20080149105 Matula Jun 2008 A1
20080178875 Henry Jul 2008 A1
20080178886 Lieberman et al. Jul 2008 A1
20080200880 Kyvik et al. Aug 2008 A1
20080210241 Schulz Sep 2008 A1
20080230068 Rudolph Sep 2008 A1
20080257354 Davidson et al. Oct 2008 A1
20080264413 Doherty Oct 2008 A1
20080264421 Kwok et al. Oct 2008 A1
20080302365 Cohen et al. Dec 2008 A1
20080314389 Thomas et al. Dec 2008 A1
20090044808 Guney et al. Feb 2009 A1
20090050156 Ng et al. Feb 2009 A1
20090065729 Worboys et al. Mar 2009 A1
20090126739 Ng et al. May 2009 A1
20090138527 Ng et al. May 2009 A1
20090139526 Melidis et al. Jun 2009 A1
20090145429 Ging et al. Jun 2009 A1
20090151729 Judson et al. Jun 2009 A1
20090173343 Omura et al. Jul 2009 A1
20090217929 Kwok et al. Sep 2009 A1
20090223518 Kwok et al. Sep 2009 A1
20090223521 Howard et al. Sep 2009 A1
20090223523 Chang Sep 2009 A1
20100000534 Kooij et al. Jan 2010 A1
20100000543 Berthon-Jones et al. Jan 2010 A1
20100018534 Veliss et al. Jan 2010 A1
20100043800 Omura Feb 2010 A1
20100089401 Lang et al. Apr 2010 A1
20100132717 Davidson et al. Jun 2010 A1
20100192955 Biener et al. Aug 2010 A1
20100258132 Moore Oct 2010 A1
20100282265 Melidis et al. Nov 2010 A1
20100300447 Biener et al. Dec 2010 A1
20100319700 Ng et al. Dec 2010 A1
20110030692 Jones et al. Feb 2011 A1
20110056497 Scheiner et al. Mar 2011 A1
20110220110 Frater et al. Sep 2011 A1
20110220114 Lithgow et al. Sep 2011 A1
20110226254 Lang et al. Sep 2011 A1
20110259337 Hitchcock et al. Oct 2011 A1
20120138063 Eves et al. Jun 2012 A1
20120174928 Raje et al. Jul 2012 A1
20120266886 Davidson et al. Oct 2012 A1
20130037033 Hitchcock et al. Feb 2013 A1
20130081628 Davidson et al. Apr 2013 A1
20130081629 Davidson et al. Apr 2013 A1
20130081630 Davidson et al. Apr 2013 A1
20130081631 Davidson et al. Apr 2013 A1
20130081632 Davidson et al. Apr 2013 A1
20130086795 Davidson et al. Apr 2013 A1
20130086796 Davidson et al. Apr 2013 A1
20130087147 Davidson et al. Apr 2013 A1
20130087148 Davidson et al. Apr 2013 A1
20130087149 Davidson et al. Apr 2013 A1
20130092168 Davidson et al. Apr 2013 A1
20130092170 Davidson et al. Apr 2013 A1
20130133658 Ng et al. May 2013 A1
20130133660 Ng et al. May 2013 A1
20140202466 Ho Jul 2014 A1
20140338672 D'Souza et al. Nov 2014 A1
20140373847 Ng et al. Dec 2014 A2
20170043113 Ng et al. Feb 2017 A1
20170157352 Ng et al. Jun 2017 A1
20170340850 Ng et al. Nov 2017 A1
20180021536 Ng et al. Jan 2018 A1
20180243522 Ng et al. Aug 2018 A1
20210322703 Ng et al. Oct 2021 A1
20210402122 Ng et al. Dec 2021 A1
20220313936 Ng et al. Oct 2022 A1
Foreign Referenced Citations (295)
Number Date Country
9177110 Nov 1991 AU
9464816 Dec 1994 AU
9516178 Jul 1995 AU
9459430 Oct 1995 AU
9532914 Feb 1996 AU
9651130 Oct 1996 AU
9741018 Apr 1998 AU
9889312 Jan 1999 AU
2005100738 Nov 2005 AU
200600031 Jan 2006 AU
618807 Apr 1961 CA
623129 Jul 1961 CA
1039144 Sep 1978 CA
1219883 Jun 1999 CN
2464353 Dec 2001 CN
1901962 Dec 2004 CN
1623609 Jun 2005 CN
1735439 Feb 2006 CN
1972727 May 2007 CN
2902337 May 2007 CN
101102807 Jan 2008 CN
185 017 May 1907 DE
284 800 Nov 1913 DE
459 104 Apr 1928 DE
701 690 Jan 1941 DE
30 11 900 Oct 1980 DE
146 688 Jan 1981 DE
30 15 279 Oct 1981 DE
31 49 449 Oct 1982 DE
159 396 Mar 1983 DE
33 45 067 Jun 1984 DE
37 07 952 Mar 1987 DE
35 37 507 Apr 1987 DE
35 39 073 May 1987 DE
37 19 009 Dec 1988 DE
39 27 038 Feb 1991 DE
40 04 157 Apr 1991 DE
42 12 259 Jan 1993 DE
42 33 448 Apr 1993 DE
43 43 205 Jun 1995 DE
195 48 380 Jul 1996 DE
196 03 949 Aug 1997 DE
297 15 718 Oct 1997 DE
197 35 359 Jan 1998 DE
297 23 101 Jul 1998 DE
197 03 526 Aug 1998 DE
298 10 846 Aug 1998 DE
198 17 332 Jan 1999 DE
198 07 961 Aug 1999 DE
198 08 105 Sep 1999 DE
198 40 760 Mar 2000 DE
200 05 346 May 2000 DE
299 23 141 May 2000 DE
200 17 940 Feb 2001 DE
199 44 242 Mar 2001 DE
199 54 517 Jun 2001 DE
100 02 571 Jul 2001 DE
199 62 515 Jul 2001 DE
100 45 183 May 2002 DE
102 13 905 Oct 2002 DE
10 2004 055 433 Nov 2004 DE
103 31 837 Jan 2005 DE
696 33 023 Jan 2005 DE
20 2004 018 108 Feb 2005 DE
103 38 169 Mar 2005 DE
0 054 154 Jun 1982 EP
0 252 052 Jan 1988 EP
0 264 772 Apr 1988 EP
0 288 937 Nov 1988 EP
0 334 555 Sep 1989 EP
0 386 605 Sep 1990 EP
0 427 474 May 1991 EP
0 462 701 Dec 1991 EP
0 466 960 Jan 1992 EP
0 303 090 Apr 1992 EP
0 549 299 Jun 1993 EP
0 602 424 Jun 1994 EP
0 608 684 Aug 1994 EP
0 658 356 Jun 1995 EP
0 697 225 Feb 1996 EP
0 178 925 Apr 1996 EP
0 747 078 Dec 1996 EP
0 776 679 Jun 1997 EP
0 821 978 Feb 1998 EP
0 853 962 Jul 1998 EP
1 027 905 Aug 2000 EP
1 057 494 Dec 2000 EP
1 099 452 May 2001 EP
1 118 346 Jul 2001 EP
1 163 923 Dec 2001 EP
0 830 180 Mar 2002 EP
1 205 205 May 2002 EP
1 258 266 Nov 2002 EP
1 356 843 Oct 2003 EP
1 360 971 Nov 2003 EP
1 481 702 Dec 2004 EP
1 982 740 Oct 2008 EP
2 022 528 Feb 2009 EP
2 027 880 Feb 2009 EP
2 471 566 Jul 2012 EP
2 471 567 Jul 2012 EP
780018 Apr 1935 FR
2 574 657 Jun 1986 FR
2 658 725 Aug 1991 FR
2 720 280 Dec 1995 FR
2 735 030 Dec 1996 FR
2 749 176 Dec 1997 FR
2 823 122 Oct 2002 FR
532 214 Jan 1941 GB
649 689 Jan 1951 GB
823 887 Nov 1959 GB
880942 Oct 1961 GB
1 392 621 Apr 1975 GB
1 395 391 May 1975 GB
1 467 828 Mar 1977 GB
2 145 335 Mar 1985 GB
2 147 506 May 1985 GB
2 164 569 Mar 1986 GB
2 176 404 Dec 1986 GB
2 186 801 Aug 1987 GB
2 267 648 Dec 1993 GB
2 368 533 May 2002 GB
2 385 533 May 2003 GB
2 397 244 Jul 2004 GB
S39-13991 Jul 1964 JP
S51-142793 Nov 1976 JP
H03-007173 Jan 1991 JP
H09-216240 Aug 1997 JP
H11-000397 Jan 1999 JP
H11-104256 Apr 1999 JP
H11-508159 Jul 1999 JP
2000-279520 Oct 2000 JP
2000-325481 Nov 2000 JP
2000-515784 Nov 2000 JP
2002-028240 Apr 2002 JP
2002-543943 Dec 2002 JP
2003-175106 Jun 2003 JP
2003-535657 Dec 2003 JP
2004-000570 Jan 2004 JP
2004-526464 Sep 2004 JP
2005-337371 Dec 2005 JP
2006-505373 Feb 2006 JP
3802872 Jul 2006 JP
2007-167671 Jul 2007 JP
2008501438 Jan 2008 JP
2008526391 Jul 2008 JP
2008532659 Aug 2008 JP
2008541955 Nov 2008 JP
2011-512967 Apr 2011 JP
6657302 Mar 2020 JP
WO 8001044 May 1980 WO
WO 8203548 Oct 1982 WO
WO 8606969 Dec 1986 WO
WO 8701950 Apr 1987 WO
WO 9103277 Mar 1991 WO
WO 9215353 Sep 1992 WO
WO 9220392 Nov 1992 WO
WO 9220395 Nov 1992 WO
WO 9301854 Feb 1993 WO
WO 9324169 Dec 1993 WO
WO 9402190 Feb 1994 WO
WO 9416759 Aug 1994 WO
WO 9420051 Sep 1994 WO
WO 9502428 Jan 1995 WO
WO 9617643 Jun 1996 WO
WO 9625983 Aug 1996 WO
WO 9628207 Sep 1996 WO
WO 9639206 Dec 1996 WO
WO 9640370 Dec 1996 WO
WO 9700092 Jan 1997 WO
WO 9707847 Mar 1997 WO
WO 9709090 Mar 1997 WO
WO 9720597 Jun 1997 WO
WO 9741911 Nov 1997 WO
WO 9803145 Jan 1998 WO
WO 9804310 Feb 1998 WO
WO 9811930 Mar 1998 WO
WO 9812965 Apr 1998 WO
WO 9818514 May 1998 WO
WO 9823305 Jun 1998 WO
WO 9824499 Jun 1998 WO
WO 9826829 Jun 1998 WO
WO 9826830 Jun 1998 WO
WO 9834665 Aug 1998 WO
WO 9848878 Nov 1998 WO
WO 9916327 Apr 1999 WO
WO 9925410 May 1999 WO
WO 9943375 Sep 1999 WO
WO 9958181 Nov 1999 WO
WO 9961088 Dec 1999 WO
WO 9965554 Dec 1999 WO
WO 0020072 Apr 2000 WO
WO 0021600 Apr 2000 WO
WO 0035525 Jun 2000 WO
WO 0038772 Jul 2000 WO
WO 0050121 Aug 2000 WO
WO 0050122 Aug 2000 WO
WO 0057942 Oct 2000 WO
WO 0069521 Nov 2000 WO
WO 0072905 Dec 2000 WO
WO 0074758 Dec 2000 WO
WO 0076568 Dec 2000 WO
WO 0078381 Dec 2000 WO
WO 0078384 Dec 2000 WO
0162326 Aug 2001 WO
200162326 Aug 2001 WO
WO 0162326 Aug 2001 WO
WO 0195965 Dec 2001 WO
WO 0197892 Dec 2001 WO
WO 0197893 Dec 2001 WO
WO 0211804 Feb 2002 WO
WO 0232491 Apr 2002 WO
WO 0238221 May 2002 WO
WO 0245784 Jun 2002 WO
WO 0247749 Jun 2002 WO
WO 03005931 Jan 2003 WO
WO 03059427 Jul 2003 WO
WO 03082406 Oct 2003 WO
WO 03090827 Nov 2003 WO
WO 03105921 Dec 2003 WO
WO 2004007010 Jan 2004 WO
WO 2004022144 Mar 2004 WO
WO 2004022145 Mar 2004 WO
WO 2004022146 Mar 2004 WO
WO 2004022147 Mar 2004 WO
2004041341 May 2004 WO
WO 2004041342 May 2004 WO
WO 2004071565 Aug 2004 WO
WO 2004073778 Sep 2004 WO
WO 2004078228 Sep 2004 WO
WO 2004078230 Sep 2004 WO
WO 2004096332 Nov 2004 WO
WO 2005002656 Jan 2005 WO
WO 2005004974 Jan 2005 WO
WO 2005018523 Mar 2005 WO
WO 2005021075 Mar 2005 WO
WO 2005028010 Mar 2005 WO
WO 2005051468 Jun 2005 WO
WO 2005053781 Jun 2005 WO
WO 2005063326 Jul 2005 WO
WO 2005063328 Jul 2005 WO
WO 2005086943 Sep 2005 WO
WO 2005094928 Oct 2005 WO
WO 2005099801 Oct 2005 WO
WO 2005110220 Nov 2005 WO
WO 2005118040 Dec 2005 WO
WO 2005123166 Dec 2005 WO
WO 2006000046 Jan 2006 WO
WO 2006014630 Feb 2006 WO
WO 2006052653 May 2006 WO
WO 2006069345 Jun 2006 WO
2006074514 Jul 2006 WO
WO 2006069415 Jul 2006 WO
WO 2006074513 Jul 2006 WO
WO 2006074515 Jul 2006 WO
WO 2006074516 Jul 2006 WO
WO 20060745514 Jul 2006 WO
WO 2006096924 Sep 2006 WO
WO 2006099658 Sep 2006 WO
WO 2006102707 Oct 2006 WO
2006133480 Dec 2006 WO
WO 2006130903 Dec 2006 WO
WO 2006138416 Dec 2006 WO
WO 2007009182 Jan 2007 WO
2007045008 Apr 2007 WO
WO 2007041751 Apr 2007 WO
WO 2007041786 Apr 2007 WO
2007059504 May 2007 WO
WO 2007048174 May 2007 WO
WO 2007053878 May 2007 WO
2007115153 Oct 2007 WO
2007143792 Dec 2007 WO
WO 2007143772 Dec 2007 WO
WO 2007143792 Dec 2007 WO
WO 2007145534 Dec 2007 WO
WO 2007147088 Dec 2007 WO
WO 2008007985 Jan 2008 WO
WO 2008011682 Jan 2008 WO
WO 2008011683 Jan 2008 WO
WO 2008040050 Apr 2008 WO
2008053715 May 2008 WO
WO 2008058330 May 2008 WO
WO 2008070929 Jun 2008 WO
WO 2008106716 Sep 2008 WO
WO 2009026627 Mar 2009 WO
WO 2009052560 Apr 2009 WO
WO 2009062265 May 2009 WO
WO 2009108994 Sep 2009 WO
WO 2009108995 Sep 2009 WO
WO 2009109004 Sep 2009 WO
WO 2010028425 Mar 2010 WO
WO 2010066004 Jun 2010 WO
WO 2011060479 May 2011 WO
WO 2013057647 Apr 2013 WO
WO 2013061260 May 2013 WO
Non-Patent Literature Citations (508)
Entry
Office Action dated Mar. 23, 2021 issued in Chinese Application No. 201910247029.2 with English translation (21 pages).
Office Action dated Apr. 5, 2021 issued in Japanese Application No. 2020-016999 with English translation (8 pages).
Extended European Search Report dated May 4, 2021 issued in European Application No. 20214255.0 (31 pages).
Further Examination Report dated May 12, 2021 issued in New Zealand Application No. 768736 (1 page).
Notice of Opposition dated Oct. 20, 2014 issued in Australian Application No. 2009221630 (2 pages).
Communication dated Jun. 14, 2016 issued in Australian Application No. 2009221630 (48 pages).
Communication dated Sep. 21, 2015 issued in Australian Application No. 2009221630 (48 pages).
Decision dated Jul. 15, 2016 issued in Australian Application No. 2009221630 (45 pages).
Affidavit of Arthur Lucian Howden Roberts dated Nov. 30, 2016 Australian Application No. 2009221630 (256 pages).
Statutory Declaration of Christopher Earl Nightingale dated Apr. 17, 2015 in Australian Application No. 2009221630 (1 page).
Statutory Declaration of Alistair Edwin McAuley dated Apr. 9, 2015 in Australian Application No. 2009221630 (39 pages).
Second Statutory Declaration of Alistair Edwin McAuley dated Apr. 14, 2015 in Australian Application No. 2009221630 (6 pages).
Third Statutory Declaration of Alistair Edwin McAuley dated Apr. 17, 2015 in Australian Application No. 2009221630 (11 pages).
Statutory Declaration of Dr. David Maurice Rapoport dated Apr. 2, 2015 in Australian Application No. 2009221630 (46 pages).
Notice of Filing dated Dec. 22, 2016 of Sealed Second Affidavit of Alistair Edwin McAuley in Australian Application No. 2009221630 (432 pages).
Office Action dated May 7, 2019 issued in Japanese Application No. 2018-107697 with English translation (13 pages).
Notice of Filing dated Dec. 1, 2016 of Sealed Affidavit of Arthur Lucian Howden Roberts in Australian Application No. 2009221630 (256 pages).
Notice of Filing dated Dec. 5, 2016 of Sealed Affidavit of Alastair Edwin McAuley in Australian Application No. 2009221630 (223 pages).
Notice of Filing dated Jan. 31, 2017 of Sealed Affidavit of Arthur Lucian Howden Roberts in Australian Application No. 2009221630 (93 pages).
Notice of Filing dated Jan. 31, 2017 of Sealed Affidavit of Alastair Edwin McAuley in Australian Application No. 2009221630 (284 pages).
Statutory Declaration of Alistair Edwin McAuley dated Sep. 16, 2015 in Australian Application No. 2009221630 (10 pages).
Statutory Declaration of Troy Alan Baker dated Apr. 16, 2015 in Australian Application No. 2009221630 (36 pages).
Notification dated Jan. 18, 2021 issued in European Application No. 13197251.5 (3 pages).
Opponent's Letter dated Dec. 22, 2020 filed in European Application No. 13197251.5 (80 pages).
Communication dated Apr. 18, 2019 issued in European Application No. 13197251.5 (43 pages).
Statutory Declaration of Daniel Anthony Hearn of Feb. 21, 2019 (28 pages).
EP Communication from the Board of Appeals dated Nov. 15, 2019 (1 page), with Letter of the Opponent Dated Oct. 28, 2019 (36 pages), with Exhibit D34 Affidavit of Robert Malloy, Ph.D. (11 pages) and Exhibit D35 Affidavit of John Shi-Nash (27 pages), total 75 pages.
Notification of the First Office Action dated Dec. 30, 2019 in Chinese Application No. 2018100740697, with English translation (24 pages).
Office Action dated Jan. 17, 2020 issued in U.S. Appl. No. 15/335,684 (153 pages).
Pellethane specs at Microspec https://www.microspecorporation.com/materials/polyurethanes/pellethane/accessed1/113/2020 (Year: 2020).
Interlocutory Decision in Opposition Proceedings (Art. 101(3)(a) and 106(2) EPC) dated Nov. 26, 2018 in European Application No. 13 197 251.5 (EP Patent 2 708 258), 28 pages, and Documents Relating to Amended Text, 102 pages (130 pages total).
Minutes of Oral Proceedings mailed Nov. 26, 2018 in European Application No. 13 197 251.5 (EP Patent 2 708 258), 11 pages.
Opponent's Statement Setting Out the Grounds of Appeal mailed Jan. 23, 2019 in European Application No. 13 197 251.5 (EP Patent 2 708 258), Appeal Number T3024/18-3.2.02, 88 pages.
Exhibit N6a, Feature Analysis of Maintained Claim 1 of EP 2 708 258, filed Jan. 18, 2019 with Opponent's Statement Setting Out the Grounds of Appeal, 1 page.
Exhibit N7, Summons from the District Court Munich Dealing with the Parallel Infringement Case Docket No. 7 O 15820/16, filed Jan. 18, 2019 with Opponent's Statement Setting Out the Grounds of Appeal, 2 pages.
First Examination Report issued in related New Zealand Application No. 748881 dated Jan. 9, 2019, (2 pages).
Exhibit VP20, Excerpt from Wikipedia for “Interference Fit”, date unknown, submitted by ResMed Limited in European Application No. 13 19 7251.5 (EP Patent 2708258) on Sep. 12, 2017, 3 pages.
Exhibit VP21, Excerpt from Wikipedia for “Verbindungstechnik,” date unknown, submitted by ResMed Limited in European Application No. 13 19 7251.5 (EP Patent 2708258) on Sep. 12, 2017, 3 pages.
Exhibit D5a, Malloy, Robert A., “Plastic Part Design for Injection Molding, An Introduction,” 2nd Edition, Hanser Publishers, Munich, Germany, 2010, filed on Sep. 12, 2017 by ResMed Limited in European Application No. 13 19 7251.5 (EP Patent 2708258), 15 pages.
Exhibit D14a (D14 plus further pages), Delpy et al., “Schnappverbindungen aus Kunststoff,” ISBN 3-8169-0488-2, 1989, 18 pages.
Exhibit D17, Affidavit of Gregory Olsen executed Jun. 29, 2018 and filed and filed Jan. 18, 2019 with Opponent's Statement Setting Out the Grounds of Appeal, 2 pages.
Exhibit VP03, Merriam-Webster dictionary definition of “snap”, 2018, filed by ResMed Limited in European Application No. 13 19 7251.5 (EP Patent 2708258) on Aug. 17, 2018, 19 pages.
Exhibit D27, Expert Report of John Shi-Nash (unsigned), dated Jul. 28, 2017, In the High Court of Justice Chancery Division Patents Court, Claim Nos. HP-2016-000050 and HP-2016-000054, filed Jan. 18, 2019 with Opponent's Statement Setting Out the Grounds of Appeal, 161 pages.
Exhibit D28, Second Expert Report of John Shi-Nash, dated Sep. 13, 2017, In the High Court of Justice Chancery Division Patents Court, Claim Nos. HP-2016-000050 and HP-2016-000054, filed Jan. 18, 2019 with Opponent's Statement Setting Out the Grounds of Appeal, 34 pages.
Exhibit D29, Affidavit of John Shi-Nash, including Exhibits 1 and 2, executed Jan. 17, 2019 and filed Jan. 18, 2019 with Opponent's Statement Setting Out the Grounds of Appeal, 27 pages.
Exhibit D30, Affidavit of Robert Malloy, Ph.D. including Exhibits 1 and 2, executed Jan. 11, 2019 and filed Jan. 18, 2019 with Opponent's Statement Setting Out the Grounds of Appeal, 21 pages.
Response filed by ResMed Limited in European Appln. No. 13 19 7251.5 (EP Patent 2708258) on Sep. 12, 2017, 35 pages.
Preliminary Remarks filed by ResMed Limited in European Appln. No. 13 19 7251.5 (EP Patent 2708258) on Dec. 22, 2017, 30 pages.
Exhibit VP01, “Excerpt from a letter dated Mar. 31, 2017 of the opponent,” filed by ResMed Limited in European Application No. 13 19 7251.5 (EP Patent 2708258) on Dec. 22, 2017, 2 pages.
Written Submissions filed Aug. 17, 2018 by ResMed Limited in European Application No. 13 19 7251.5 (EP Patent 2708258), 30 pages.
Letter filed by AJ Park on behalf of Fisher & Paykel Healthcare Limited in corresponding New Zealand Application Nos. 607032, 622666, and 622670, on Feb. 22, 2019 (2 pages).
Statutory Declaration of Alastair Edwin McAuley with Exhibits AM-M1A, AM-M1B, AM-M2A, and photos of Exhibit AM-M4B, executed Feb. 19, 2019 and filed by AJ Park on behalf of Fisher & Paykel Healthcare Limited on Feb. 22, 2019 in corresponding New Zealand Application Nos. 607032, 622666, 622670, 7011136, 701183 and 624599 (26 pages).
Fourth Office Action issued in related Chinese Application No. 201510341599X dated Aug. 20, 2018, with English translation, (8 pages).
Opponent's Submission—European Brief Communication dated Aug. 23, 2018 and enclosing Letter to EPO filed by Bird & Bird on behalf of Fisher & Paykel Healthcare Limited in related European Patent No. 2 708 258 B1/European Application No. 13 197 251.5 (10 pages).
Pre-Appeal Examination Report issued in related Japanese Application No. 2016-92520 dated Aug. 20, 2018, with English translation, (3 pages).
Decision of the Commissioner issued in related New Zealand Application Nos. 622666, 622670, and 607032 dated Oct. 10, 2018, (81 pages).
Examination Report issued in related European Application No. 09716457.8 dated Oct. 12, 2018, (9 pages).
Final Written Decision dated Oct. 23, 2018 in Fisher & Paykel Healthcare Limited v. ResMed Limited, Case No. IPR2017-00501, U.S. Pat. No. 9,027,556 B2 (99 pages).
Letter filed by AJ Park on behalf of Fisher & Paykel Healthcare Limited in corresponding New Zealand Application Nos. 701136 and 701183, on Jun. 27, 2018 (2 pages).
Third Amended Statement of Case (clean) dated Jun. 27, 2018 filed in corresponding New Zealand Application No. 701183 (28 pages).
Third Amended Statement of Case (marked-up) dated Jun. 27, 2018 filed in corresponding New Zealand Application No. 701183 (28 pages).
Statutory Declaration of Daniel Anthony Hearn with Exhibits DH-1 to DH-26, dated Jun. 1, 2018 and filed in corresponding New Zealand Application Nos. 607032, 622666, 622670, 7011136, 701183 and 624599 (232 pages).
Fifth Amended Statement of Case (clean) dated Jun. 27, 2018 filed in corresponding New Zealand Application No. 701136 (31 pages).
Fifth Amended Statement of Case (marked-up) dated Jun. 27, 2018 filed in corresponding New Zealand Application No. 701136 (31 pages).
Letter filed by AJ Park on behalf of Fisher & Paykel Healthcare Limited dated Jul. 6, 2018 in corresponding New Zealand Application Nos. 607032, 622666, 622670, 701136, and 701183 (1 page).
Statutory Declaration of Alastair Edwin McAuley with Exhibits AM-MI to AM-M16, dated Jul. 6, 2018 and filed in corresponding New Zealand Application Nos. 607032, 622666, 622670, 7011136, 701183 and 624599 (18 pages).
Brief Communication issued in corresponding European Application No. 13197251.5-1122 dated Jul. 5, 2018 (39 pages).
Summons to attend oral proceedings pursuant to Rule 115(1) EPC and Preliminary Opinion issued in corresponding European Application No. 13197251.5-1122 dated Mar. 2, 2018 (7 pages).
Letter filed by AJ Park on behalf of Fisher & Paykel Healthcare Limited in corresponding New Zealand Application Nos. 607032, 622666, and 622670, on Jun. 22, 2018 (3 pages).
Letter filed by AJ Park on behalf of Fisher & Paykel Healthcare Limited in corresponding New Zealand Application Nos. 607032, 622666, 622670, 701136, and 701183, on Jun. 25, 2018 (2 pages).
Fisher & Paykel Healthcare's Opponent's Submissions—Objections to Applicant's Evidence and Cross-Examination in corresponding New Zealand Application Nos. 622666, 622670, and 607032, dated May 31, 2018 (22 pages).
Fisher & Paykel Healthcare's Reply Submissions of the Opponent for the Interlocutory Hearing of 28, 29, Jun. 2018 in corresponding New Zealand Application Nos. 622666, 622670, and 607032, dated Jun. 14, 2018 (47 pages).
Letter filed by AJ Park on behalf of Fisher & Paykel Healthcare Limited in corresponding New Zealand Application No. 624599 on Jun. 1, 2018 (3 pages).
Statutory Declaration of Jonathan Ellis dated Oct. 27, 2017 and filed in corresponding New Zealand Application Nos. 622666, 622670, 607032, 624599, 612787, 701136, and 701183 (30 pages).
Statutory Declaration of Jessica Michele Vranjes dated Nov. 10, 2017 and filed in corresponding New Zealand Application Nos. 622666, 622670, 607032, 624599, 612787, 701136, and 701183 (8 pages).
Statutory Declaration of Daniel Anthony Hearn dated Jun. 1, 2018 and filed in corresponding New Zealand Application Nos. 607032, 622666, 622670, 701136, 701183, and 624599 (232 pages).
Second Amended Statement of Case (clean) dated Jun. 1, 2018 filed in corresponding New Zealand Application No. 624599 (41 pages).
Second Amended Statement of Case (tracked) dated Jun. 1, 2018 filed in corresponding New Zealand Application No. 624599 (54 pages).
Fourth Amended Notice of Opposition to Grant of Patent (Section 21) (clean) dated Jun. 1, 2018 filed in corresponding New Zealand Application No. 624599 (4 pages).
Fourth Amended Notice of Opposition to Grant of Patent (Section 21) (tracked) dated Jun. 1, 2018 filed in corresponding New Zealand Application No. 624599 (7 pages).
Letter filed by AJ Park on behalf of Fisher & Paykel Healthcare Limited in corresponding New Zealand Application No. 624599 on Jun. 5, 2018 (1 page).
Statutory Declaration of Alastair Edwin McAuley with dated Jun. 2, 2018 and filed in corresponding New Zealand Application No. 624599 (105 pages).
Third Statutory Declaration of Alastair Edwin McAuley dated Jun. 2, 2018 and filed in corresponding New Zealand Application No. 624599 (378 pages).
Fourth Statutory Declaration of Alastair Edwin McAuley dated Jun. 2, 2018 and filed in corresponding New Zealand Application No. 624599 (457 pages).
Letter filed by AJ Park on behalf of Fisher & Paykel Healthcare Limited in corresponding New Zealand Application No. 624599 on Jun. 6, 2018 (1 page).
Final Written Decision in Fisher & Paykel Healthcare Limited v. ResMed Limited, Case No. IPR2017-00504, U.S. Pat. No. 9,027,556 B2, dated Jun. 12, 2018 (55 pages).
U.S. Appl. No. 15/682,117, filed Aug. 21, 2017, pending.
U.S. Appl. No. 13/964,280, filed Aug. 12, 2013.
Adam J. Singer MD et al. “The Cyanoacrylate Topical Skin Adhesives,” American Journal of Emergency Medicine, vol. 26, 2008, pp. 490-496.
Australian Appln. No. 2005253641—Examiner's First Report, dated Apr. 20, 2010.
Australian Appln. No. 2005253641—Examiner's Report, dated Aug. 18, 2011.
Australian Appln. No. 2006206040—Examination Report, dated Jun. 27, 2012.
Australian Appln. No. 2010251884—Examination Report, dated Jul. 27, 2012.
Australian Appln. No. PCT/AU2009/000214—International Search Report, dated May 18, 2009.
Chinese Appln. No. 200480011911.9—Office Action (w/English translation), dated Jun. 24, 2010.
Chinese Appln. No. 200580020203.6—Office Action (w/English translation), dated Jun. 1, 2010.
Chinese Appln. No. 200580020203.6—Office Action (w/English translation), dated Jul. 6, 2011.
Chinese Appln. No. 200580020203.6—Office Action (w/English translation), dated Dec. 23, 2011.
Chinese Appln. No. 200580020203.6—Office Action (w/English translation), dated Apr. 18, 2012.
Chinese Appln. No. 200680002169.4—Office Action (w/English translation), dated Mar. 23, 2010.
Chinese Appln. No. 200680002169.4—Third Office Action (w/English translation), dated Nov. 11, 2010.
Chinese Appln. No. 200810109270.0—Office Action (w/English translation), dated Oct. 19, 2011.
Chinese Appln. No. 200810109270.0—Office Action (w/English translation), dated Jun. 27, 2012.
Chinese Appln. No. 200910223650.1—Office Action (w/English translation), dated Mar. 29, 2012.
Chinese Appln. No. 201010000226.3—Office Action (w/English translation), dated Apr. 26, 2012.
Chinese Appln. No. 201010517066.X—Office Action (w/English translation), dated Nov. 10, 2011.
ComfortLite™, Respironics, http://comfortlite.respironics.com, before applicants' filing date.
ComfortLite™ 2, Respironics, http://comfortlite2.respironics.com, before applicants' filing date.
“Ear Loop Face Mask” , before applicants' filing date.
European Appln. No. EP 01944732.5—Office Action, dated Nov. 27, 2009.
European Appln. No. EP 02714190.2—Search Report, dated Jul. 11, 2006.
European Appln. No. EP 03793493.2—Supplementary Search Report, dated Dec. 2, 2009.
European Appln. No. EP 03793493.2—Office Action, dated Mar. 18, 2011.
European Appln. No. EP 03810331.3—Supplementary Search Report, dated Dec. 18, 2009.
European Appln. No. EP 04730413.4—Supplementary Search Report, dated Sep. 29, 2009.
European Appln. No. EP 05749447.8—Supplementary Search Report, dated Dec. 8, 2009.
European Appln. No. EP 04802114.1—Supplementary Search Report, dated Apr. 27, 2009.
European Appln. No. EP 04802133.1—Supplementary Search Report, dated Sep. 8, 2009.
European Appln. No. EP 04802133.1—Office Action, dated Dec. 22, 2009.
European Appln. No. EP 05746824.1—Supplementary Search Report, dated Dec. 17, 2009.
European Appln. No. EP 06704287.9—Supplementary Search Report, dated Oct. 6, 2009.
European Appln. No. EP 06704287.9—Office Action, dated Jul. 18, 2011.
European Appln. No. EP 07784697.0—Search Report, dated Jul. 27, 2009.
European Appln. No. EP 07845378.4—Search Report, dated Dec. 1, 2009.
European Appln. No. EP 08154854.7—Extended Search Report, dated Nov. 27, 2008.
European Appln. No. EP 08154854.7—Examination Report, dated Jul. 1, 2011.
European Appln. No. EP 08161249.1—Extended Search Report, dated Mar. 19, 2009.
European Appln. No. EP 08161868.8—Search Report, dated Nov. 27, 2008.
European Appln .No. EP 09003544.5—Search Report, dated Jun. 2, 2009.
European Appln. No. EP 09161984.1—Extended Search Report, dated Sep. 3, 2009.
European Appln. No. EP 09178736.6—Search Report, dated Apr. 19, 2010.
European Appln. No. EP 10181516.5—Search Report, dated Jun. 13, 2012.
European Appln. No. EP 10182015.7—Search Report, dated Jun. 15, 2012.
European Appln. No. EP 11174401.7—Search Report, dated Oct. 20, 2011.
European Appln. No. EP 11174407.4—Extended Search Report, dated Oct. 20, 2011.
European Appln. No. EP 12154923.2—Extended Search Report, dated Jun. 1, 2012.
European Appln. No. EP 12154926.5—Extended Search Report, dated Jun. 6, 2012.
European Appln. No. EP 12165749.8—Extended Search Report, dated Oct. 10, 2012.
European Appln. No. EP 12165751.4—Extended Search Report, dated Oct. 8, 2012.
Fisher and Paykel Col.—Product Family—http://www.fphcare.com/osa/products.asp/, before applicants' filing date.
German Patent No. 101 51 984—Decision from Opposition hearing by Weinmann (w/English translation), dated Dec. 6, 2007.
Hans Rudolph, Inc.—Mask Products—http://www.rudolphkc.com/products.php?category=MASKS, before applicants' filing date.
“If You Hate CPAP! You Need CPAP Pro®,” www.cpappro.com, before applicants' filing date.
Japanese Appln. No. 2003-537718—Office Action (w/English translation), dated Oct. 7, 2008.
Japanese Appln. No. 2003-559587—Office Action (w/English translation), dated Mar. 17, 2009.
Japanese Appln. No. 2005-004072—Office Action (w/English translation), dated Sep. 24, 2009.
Japanese Appln. No. 2005-337371—Reasons for Rejection (w/English translation), dated Feb. 22, 2011.
Japanese Appln. No. 2007-515732—Office Action (w/English translation), dated Aug. 16, 2011.
Japanese Appln. No. 2005-337371—Final Office Action (w/English translation), dated Jan. 31, 2012.
Japanese Appln. No. 2006-504029—Office A545843ction (w/English translation), dated Nov. 10, 2009.
Japanese Appln. No. 2006-545843—Notice of Reasons for Rejection (w/English translation), dated Jun. 7, 2011.
Japanese Appln. No. 2007-515732—Office Action (w/English translation), dated Aug. 24, 2010.
Japanese Appln. No. 2007-515732—Office Action (w/English translation), dated Jun. 12, 2012.
Japanese Appln. No. 2007-550636—Office Action (w/English translation), dated Mar. 18, 2011.
Japanese Appln. No. 2007-550636—Office Action (w/English translation), dated Mar. 21, 2012.
Japanese Appln. No. 2007-550636—Notice of Allowance, dated Jul. 10, 2012.
Japanese Appln. No. 2009-140433—Office Action (w/English translation), dated Aug. 20, 2011.
Japanese Appln. No. 2009-140433—Notice of Allowance, dated Sep. 4, 2012.
Japanese Appln. No. 2010-195597—Office Action (w/English translation), dated Jun. 12, 2012.
Japanese Appln. No. 2010-214485—Office Action (w/English translation), dated Jun. 12, 2012.
Japanese Appln. No. 2010-268127—Notice of Reasons for Rejection (w/English translation), dated Jun. 10, 2012.
Japanese Appln. No. 2011-038110—Office Action (w/English translation), dated Aug. 14, 2012.
Japanese Appln. No. S52-164619—English translation of Figure 1, Dec. 1977.
Joel W. Beam, “Tissue Adhesives for Simple Traumatic Lacerations,” Journal of Athletic Training, 2008, vol. 43, No. 2, pp. 222-224.
JP 11-000397A Machine Translation, provided by the Japanese Patent Office, Jan. 6, 2009, full document.
Laurent Brochard, “Pressure Support Ventilation,” Chapter 9, Part IV—Conventional Methods of Ventilator Support, pp. 239-257, 1994.
Mask 1 Photographs, Respironics Inc., Reusable Full Mask (small) Part #452033 Lot #951108, before applicants' filing date.
Mask 2 Photographs, Puritan—Bennett, Adam Curcuit, Shell Part #231700, Swivel Part #616329-00, Pillows (medium) Part #616324, before applicants' filing date.
Mask 3 Photographs, DeVilbiss Healthcare Inc., Devilbiss Seal-Ring and CPAP Mask Kit (medium), Part #73510-669, before applicants' filing date.
Mask 4 Photographs, Respironics Inc., Monarch Mini Mask with Pressure Port, Part #572004, Monarch Headgear, Part #572011, before applicants' filing date.
Mask 5 Photographs, Healthdyne Technologies, Nasal CPAP Mask (medium narrow), Part #702510, before applicants' filing date.
Mask 6 Photographs, Healthdyne Technologies, Soft Series Nasal CPAP Mask, Part #702020, before applicants' filing date.
Mask 7 Photographs, DeVilbiss Healthcare Inc., Small Mask and Seal Rings, Part #73510-668, before applicants' filing date.
Mask 8 Photographs, Respironics Inc., Reusable Contour Mask (medium), Part #302180, before applicants' filing date.
Mask 9 Photographs, Healthdyne Technologies, Healthdyne Large Headgear, before applicants' filing date.
Mask 10 Photographs, Respironics Inc., Soft Cap (medium), Part #302142, before applicants' filing date.
Mask 11 Photographs, Weinmann: Hamburg, Nasalmaskensystem mit Schalldämpfer (medium), Part #WN 23105, before applicants' filing date.
Mask 12 Photographs, Life Care, before applicants' filing date.
Mask 13 Photographs, Healthdyne Technologies, before applicants' filing date.
Mask 14 Photographs, King System, before applicants' filing date.
Mask 15 Photographs, Respironics Inc., Pediatric Mask, before applicants' filing date.
Mask 16 Photographs, Hans Rudolph Inc., Hans Rudolph Silicone Rubber Face Mask/8900, before applicants' filing date.
McPherson et al., “Respiratory Therapy Equipment,” Chapter 8, Third Edition, Introduction to Ventilators, pp. 230-253, 1985.
Merriam-Webster Online Dictionary definition of moveable from the 14th century, before applicants' filing date.
New Zealand Appln. No. 2003275762—Examiner's Report No. 3, dated Nov. 18, 2009.
New Zealand Appln. No. 539836—Examination Report, dated Aug. 25, 2005.
New Zealand Appln. No. 564877—Examination Report, dated Dec. 2, 2009.
New Zealand Appln. No. 567375—Examination Report, dated Nov. 17, 2009.
New Zealand Appln. No. 587344—Examination Report, dated Jan. 19, 2012.
New Zealand Appln. No. 587344—Examination Report, dated Aug. 3, 2012.
New Zealand Appln. No. 587820—Examination Report, dated Sep. 13, 2010.
New Zealand Appln. No. 597552—Examination Report, dated Jan. 19, 2012.
New Zealand Appln. No. 597689—Examination Report, dated Jan. 25, 2012.
PCT/AU2003/001163—International Search Report, dated Nov. 4, 2003.
PCT/AU2003/001471—International Search Report, dated Feb. 12, 2004.
PCT/AU2004/000563—International Search Report, dated Jun. 23, 2004.
PCT/AU2004/001760—International Preliminary Report on Patentability, dated Jul. 3, 2006.
PCT/AU2004/001760—International Search Report, dated Jan. 12, 2005.
PCT/AU2004/001813—International Preliminary Report on Patentability, dated Jul. 3, 2006.
PCT/AU2004/001813—International Search Report, dated Mar. 7, 2005.
PCT/AU2004/001832—International Preliminary Report on Patentability, dated Jul. 3, 2006.
PCT/AU2004/001832—International Search Report, dated Mar. 24, 2005.
PCT/AU2005/000803—International Search Report, dated Jun. 30, 2005.
PCT/AU2005/000850—International Preliminary Report on Patentability, dated Dec. 20, 2006.
PCT/AU2005/000850—International Search Report, dated Aug. 12, 2005.
PCT/AU2006/000032—International Preliminary Report on Patentability, dated Jul. 17, 2007.
PCT/AU2006/000032—International Search Report, dated May 15, 2006.
PCT/AU2006/000770—International Search Report, dated Aug. 3, 2006.
PCT/AU2007/001936—International Search Report, dated Mar. 4, 2008.
PCT/AU2006/001570—International Search Report, dated Jan. 5, 2007.
PCT/AU2007/001051—International Search Report, dated Nov. 5, 2007.
PCT/AU2007/001052—International Search Report, dated Oct. 9, 2007.
PCT/AU2007/001456—International Search Report, dated Dec. 12, 2007.
PCT/AU2009/000240—International Search Report, dated May 21, 2009.
PCT/AU2009/000262—International Search Report, dated Jun. 9, 2009.
PCT/AU2009/001102—International Search Report, dated Dec. 11, 2009.
PCT/AU2009/001144—International Search Report, dated Dec. 8, 2009.
PCT/AU2010/000657—International Search Report, dated Sep. 9, 2010.
Product Brochure for ResMed “Sullivan® Mirage™—The Mirage is Real. A Perfect Fit-First Time,” © 1997 ResMed Limited, 4 pages.
Product Brochure for ResMed “Sullivan® Mirage™—The Mirage is Real. A Perfect Fit-First Time,” © 1998 ResMed Limited, 4 pages.
ResMed Co.—Mask Products—http://resmed.com/portal/site/ResMedUS/index.jsp?, before applicants' filing date.
ResMed Ltd., “Improving patient compliance with The ResMed Range of Mask Systems The Ultimate Interface for CPAP treatment,” before applicants' filing date, 4 pages.
Respironics Co.—Mask Family—http://masksfamily.respironics.com/, before Applicant's filing date.
Snapp Nasal Interface, Tiara Medical Systems, Inc.—http://tiaramed.com/asp_shops/shopsdisplayproducts.asp?id=109&cat=SNAPP%2A+Nasal+Interface, before applicants' filing date.
“Somnomask” brochure, 1999 along with various invoices relating to the “Somnomask”.
Somnotron CPAP—Great WM 2300 Instruction Manual, Weinmann Hamburg, 1991, 11 pages.
Subbu Venkatraman et al., “Review Skin Adhesives and Skin Adhesion 1. Transdermal Drug Delivery Systems,” Biomaterials, vol. 19, 1998, pp. 1119-1136.
The ResMed Range of Mask Systems, product brochure, Nov. 1995, 4 pages.
Unsolicited email from Elson Silva, PhD, dated Mar. 28, 2008, “Requesting IDS of U.S. Pat. No. 6,766,817 for patents on fluids moving on porosity by Unsaturated Hydraulic Flow,” (email provided in both HTML and plain text format).
Photo of Weinmann Mask (manufactured 1991).
U.S. Appl. No. 12/083,779—Office Action including PTO-892 listings, dated Feb. 17, 2012.
U.S. Appl. No. 12/083,779—Office Action including PTO-892 listings, dated Sep. 28, 2012.
U.S. Appl. No. 60/424,686, filed Nov. 8, 2002 (expired).
U.S. Appl. No. 60/483,622, filed Jul. 1, 2003 (expired).
U.S. Appl. No. 60/533,214, filed Dec. 31, 2003 (expired).
U.S. Appl. No. 60/634,802, filed Dec. 10, 2004 (expired).
U.S. Appl. No. 60/835,442, filed Aug. 4, 2006 (expired).
U.S. Appl. No. 60/643,121, filed Jan. 12, 2005 (expired).
U.S. Appl. No. 60/645,672, filed Jan. 21, 2005 (expired).
U.S. Appl. No. 60/795,615, filed Apr. 28, 2006 (expired).
U.S. Appl. No. 60/833,841, filed Jul. 28, 2006 (expired).
U.S. Appl. No. 60/852,649, filed Oct. 19, 2006 (expired).
U.S. Appl. No. 60/874,968, filed Dec. 15, 2006 (expired).
U.S. Appl. No. 60/907,856, filed Apr. 19, 2007 (expired).
U.S. Appl. No. 60/924,241, filed May 4, 2007 (expired).
U.S. Appl. No. 60/929,393, filed Jun. 25, 2007 (expired).
U.S. Appl. No. 60/935,179, filed Jul. 30, 2007 (expired).
U.S. Appl. No. 60/935,336, filed Aug. 8, 2007 (expired).
U.S. Appl. No. 60/996,160, filed Nov. 5, 2007 (expired).
U.S. Appl. No. 61/006,409, filed Jan. 11, 2008 (expired).
U.S. Appl. No. 61/064,818, filed Mar. 28, 2008 (expired).
U.S. Appl. No. 61/071,512, filed May 2, 2008 (expired).
U.S. Appl. No. 61/213,326, filed May 29, 2009 (expired).
U.S. Appl. No. 61/222,711, filed Jul. 2, 2009 (expired).
U.S. Appl. No. 61/263,175, filed Nov. 20, 2009 (expired).
U.S. Appl. No. 61/272,162, filed Aug. 25, 2009 (expired).
U.S. Appl. No. 61/272,250, filed Sep. 4, 2009 (expired).
U.S. Appl. No. 12/230,120, filed Aug. 8, 2008 (corresponds to JP 2009-0050156, Feb. 2009).
Webster's New World Dictionary, Third College Edition 1988, definition for engaged and flexible, before applicants' filing date.
Webster's Third New International Dictionary, 1993, Dictionary definition for adjustable, bendable, and mild steel, before applicants' filing date.
Notification of the First Office Action and English translation, for corresponding Chinese Application No. 200980116004.3, dated Dec. 24, 2012, 12 pages.
Notice of Reasons for Rejection and English Translation for corresponding JP Application No. 2010-548986, dated Apr. 16, 2003, 5 pages.
First Examination Report for corresponding NZ Application No. 607032, dated Feb. 18, 2013, 2 pages.
Patent Examination Report No. 1 for corresponding AU Application No. 2009221630, dated Mar. 21, 2013, 3 pages.
Office Action dated Apr. 4, 2013 in U.S. Appl. No. 13/747,772, including PTO-892.
Office Action dated Apr. 8, 2013 in U.S. Appl. No. 13/747,701, including PTO-892.
Notice of Allowance dated Mar. 28, 2013 in U.S. Appl. No. 12/736,024.
Notification of the Second Office Action and English Translation for corresponding Chinese Application No. 200980116004.3, dated Sep. 11, 2013, 14 pages.
European Search Report for corresponding European Application No. 09716457.8, dated Jan. 31, 2014, 5 pages.
Australian Patent Examination Report No. 2 for corresponding Australian Application No. 2009221630, dated Feb. 25, 2014, 3 pages.
European Search Report for corresponding European Application No. 13197251.5, dated Feb. 19, 2014, 6 pages.
Notice of Reasons for Rejection and English Translation for corresponding Japanese Application No. 2010-548986, dated Mar. 3, 2014, 5 pages.
Third Office Action issued in Chinese Application No. 200980116004.3 dated Apr. 8, 2014 (with translation).
New Zealand First Examination Report For Application No. 624599 dated May 13, 2014 (2 pages).
Innovation Patent Examination Report No. 2 dated Aug. 8, 2014 in Australian Application No. 2014100361 (5 pages).
D'Souza et al., U.S. Appl. No. 14/447,673, filed Jul. 31, 2014, entitled “Mask System”.
Notice of Opposition to Grant of Patent (Section 21) to New Zealand Patent Application No. 607032, filed Sep. 1, 2014, 7 pages.
Notice of Opposition to Grant of Patent (Section 21) to New Zealand Patent Application No. 622665, filed Sep. 1, 2014, 7 pages.
Notice of Opposition to Grant of Patent (Section 21) to New Zealand Patent Application No. 622666, filed Sep. 1, 2014, 7 pages.
Notice of Opposition to Grant of Patent (Section 21) to New Zealand Patent Application No. 622670, filed Sep. 1, 2014, 7 pages.
Application Under Regulation 168 for Extension of Time in New Zealand Patent Application Nos. 607032, 622666, 622670 and 622665, filed Sep. 1, 2014, 2 pages.
Office Action dated Sep. 17, 2014 in corresponding U.S. Appl. No. 13/747,701 (21 pages).
Amended Notice of Opposition to Grant of Patent filed by Fisher & Paykel Healthcare Limited in New Zealand Patent Application No. 622665 and Statement of Case filed on Oct. 30, 2014 (27 pages).
Amended Notice of Opposition to Grant of Patent filed by Fisher & Paykel Healthcare Limited in New Zealand Patent Application No. 622670 and Statement of Case filed on Oct. 30, 2014 (27 pages).
Amended Notice of Opposition to Grant of Patent filed by Fisher & Paykel Healthcare Limited in New Zealand Patent Application No. 607032 and Statement of Case filed on Oct. 30, 2014 (27 pages).
Amended Notice of Opposition to Grant of Patent filed by Fisher & Paykel Healthcare Limited in New Zealand Patent Application No. 622666 and Statement of Case filed on Oct. 30, 2014 (26 pages).
First Examination Report dated Oct. 24, 2014 in New Zealand Application No. 701183 (2 pages).
First Examination Report dated Oct. 21, 2014 in New Zealand Application No. 701136 (1 page).
Notification of the Fourth Office Action dated Oct. 17, 2014 in Chinese Application No. 200980116004.3, with English Translation (16 pages).
Office Action dated Dec. 8, 2014 in U.S. Appl. No. 14/447,673 (12 pages).
6 photos of ResMed S8 Escape flow generator tub and liner, the tub and liner are joined by a chemical bond resulting from co-moulding.
Japanese Office Action dated Dec. 1, 2014 in Japanese Application No. 2010-548986, with English Translation (8 pages).
Communication dated Jan. 5, 2015 (Extension of Time Granted), with Notice of Opposition filed Dec. 23, 2014, in New Zealand Application No. 624599 (9 pages).
Extended European Search Report dated Jan. 15, 2015 in European Application No. 14182823.6 (6 pages).
IP Australia Official Receipt dated Jan. 19, 2015, with Statement of Grounds and Particulars, filed in Australian Application No. 2009221630 (21 pages).
Office Action dated Feb. 3, 2015 in U.S. Appl. No. 14/447,673 (19 pages).
Communication Pursuant to Article 94(3) EPC dated Feb. 11, 2015 in European Application No. 13 197 251.5 (4 pages).
Extension of Time Granted (1 page) mailed Mar. 2, 2015 in New Zealand Application No. 701136, together with a Notice of Opposition to Grant of Patent (Section 21) (8 pages).
Extension of Time Granted (1 page) mailed Mar. 2, 2015 in New Zealand Application No. 701183, together with a Notice of Opposition to Grant of Patent (Section 21) (8 pages).
Deadline for Counterstatement (1 page) mailed Mar. 27, 2015 in New Zealand Application No. 624599, together with Amended Notice of Opposition to Grant of Patent (Section 21) (9 pages) and Statement of Case (29 pages).
Statutory Declaration of Christopher Earl Nightingale executed Apr. 17, 2015 for submission in the Opposition of Australian Application No. 2009221630 (1 page).
Statutory Declaration of Alistair Edwin McAuley executed Apr. 9, 2015 for submission in the Opposition of Australian Application No. 2009221630 (39 pages).
Second Statutory Declaration of Alistair Edwin McAuley executed Apr. 14, 2015 for submission in the Opposition of Australian Application No. 2009221630 (6 pages).
Third Statutory Declaration of Alistair Edwin McAuley executed Apr. 17, 2015 for submission in the Opposition of Australian Application No. 2009221630 (11 pages).
Statutory Declaration of Troy Alan Baker executed Apr. 16, 2015 for submission in the Opposition of Australian Application No. 2009221630 (36 pages).
Statutory Declaration of Dr. David Maurice Rapoport executed Apr. 2, 2015 for submission in the Opposition of Australian Application No. 2009221630 (45 pages).
Statement of Case dated Apr. 28, 2015 and filed by Fisher & Paykel Healthcare Limited in New Zealand Opposition No. 701136 (14 pages).
U.S. Appl. No. 13/834,189, filed Mar. 2013, Hitchcock et al.
U.S. Appl. No. 13/870,678, filed Apr. 2013, Kwok et al.
Statement of Case dated Apr. 28, 2015 and filed by Fisher & Paykel Healthcare Limited in New Zealand Opposition No. 701183 (13 pages).
Proceeding Correspondence mailed Jun. 17, 2015 in New Zealand Appln. No. 622670 (2 pages).
Proceeding Correspondence mailed Jun. 17, 2015 in New Zealand Appln. No. 607032 (2 pages).
Affirmation of Chun Cui executed Jun. 12, 2015 for submission in the Opposition of New Zealand Application Nos. 607032 (51 pages).
Statutory Declaration of Troy Alan Baker executed Apr. 16, 2015 for submission in the Opposition of New Zealand Application Nos. 607032, 622666 and 622670 (36 pages).
Statutory Declaration of Dr. David Maurice Rapoport executed Apr. 2, 2015 for submission in the Opposition of New Zealand Application Nos. 607032, 622666 and 622670 (46 pages).
Statutory Declaration of Alistair Edwin McAuley executed Apr. 9, 2015 for submission in the Opposition of New Zealand Application Nos. 607032, 622666 and 622670 (38 pages).
Second Statutory Declaration of Alistair Edwin McAuley executed Apr. 14, 2015 for submission in the Opposition of New Zealand Application Nos. 607032, 622666 and 622670 (3 pages).
Patent Examination Report No. 1 dated May 29, 2015 in Australian Application No. 2014218465 (8 pages).
Notice of Reasons for Rejection dated Jun. 30, 2015 in Japanese Application No. 2014-114555, with English Translation (11 pages).
Proceeding Correspondence mailed Jul. 20, 2015 in New Zealand Application No. 654599 (4 pages).
Extension of Time Granted mailed Oct. 22, 2015 in New Zealand Appln. No. 622666 acknowledging receipt of evidence and amended pleadings filed Oct. 15, 2015 (2 pages).
Extension of Time Granted mailed Oct. 22, 2015 in New Zealand Appln. No. 622670 acknowledging receipt of evidence and amended pleadings filed Oct. 15, 2015 (2 pages).
Extension of Time Granted mailed Oct. 22, 2015 in New Zealand Appln. No. 607032 acknowledging receipt of evidence and amended pleadings filed Oct. 15, 2015 (2 pages).
Declaration of Haydn Llewellyn dated Sep. 23, 2015 (3 pages), with 1 Exhibit (1 page) relating to the sale of HC431 Full Face Mask filed in New Zealand Appln. Nos. 607032, 622666, 622670, 624599, 701136, 701183, 612787, and 599406.
Second Amended Notice of Opposition to Grant of Patent (Section 21) (clean and marked up) filed Oct. 15, 2015 in New Zealand Appln. No. 622666 (20 pages).
First Amended Statement of Case (clean and marked up) filed Oct. 15, 2015 in New Zealand Appln. No. 622666 (32 pages).
Second Amended Notice of Opposition to Grant of Patent (Section 21) (clean and marked up) filed Oct. 15, 2015 in New Zealand Appln. No. 622670 (20 pages).
First Amended Statement of Case (clean and marked up) filed Oct. 15, 2015 in New Zealand Appln. No. 622670 (36 pages).
Third Statutory Declaration of Alastair Edwin McAuley dated Oct. 15, 2015 and filed in New Zealand Appln. No. 622670 (22 pages).
Second Amended Notice of Opposition to Grant of Patent (Section 21) (clean and marked up) filed Oct. 15, 2015 in New Zealand Appln. No. 607032 (22 pages).
First Amended Statement of Case (clean and marked up) filed Oct. 15, 2015 in New Zealand Appln. No. 607032 (43 pages).
Third Statutory Declaration of Alastair Edwin McAuley dated Oct. 15, 2015 and filed in New Zealand Appln. No. 607032 (20 pages).
Communication pursuant to Article 94(3) EPC dated Nov. 27, 2015 in EP Appln. No. 14 182 823.6 (5 pages).
Deadline for Applicant to File Evidence mailed Nov. 17, 2015 in New Zealand Appln. No. 607032 (2 pages).
Deadline for Applicant to File Evidence mailed Nov. 17, 2015 in New Zealand Appln. No. 622666 (2 pages).
Deadline for Applicant to File Evidence mailed Nov. 17, 2015 in New Zealand Appln. No. 622670 (2 pages).
Third Amended Notice of Opposition to Grant of Patent (marked up and clean) filed Nov. 16, 2015 in New Zealand Appln. No. 607032 (20 pages).
Second Amended Statement of Case (marked up and clean) filed Nov. 16, 2015 in New Zealand Appln. No. 607032 (40 pages).
Affirmation of Nicola Jane Kahn with Exhibits NJK-1 to NJK-4 dated Nov. 6, 2015 for New Zealand Appln. No. 607032 (17 pages).
Second Affirmation of Nicola Jane Kahn with Exhibits NJK-5 to NJK-7 dated Nov. 13, 2015 for New Zealand Appln. No. 607032 (7 pages).
Statutory Declaration of John Dominic Simpson with Exhibits JDS-1 to JDS-13 dated Nov. 11, 2015 for New Zealand Appln. Nos. 622666, 622670, 607032, 624599, 701136 and 701183 (48 pages).
Statutory Declaration of Christopher Bryn Sparks dated Nov. 11, 2015 for New Zealand Appln. Nos. 622666, 622670, 607032, 624599, 701136 and 701183 (2 pages).
Fourth Statutory Declaration of Alastair Edwin McAuley with Exhibit AM-3 dated Nov. 11, 2015 with Exhibit AM-3 for New Zealand Appln. No. 607032 (23 pages).
Statutory Declaration of Gregory James Olsen with Exhibits GO-1 and GO-2 dated Nov. 16, 2015 for New Zealand Appln. No. 607032 (7 pages).
Third Amended Notice of Opposition to Grant of Patent (marked up and clean) filed Nov. 16, 2015 in New Zealand Appln. No. 622666 (18 pages).
Second Amended Statement of Case (marked up and clean) filed Nov. 16, 2015 in New Zealand Appln. No. 622666 (16 pages).
Affirmation of Nicola Jane Kahn with Exhibits NJK-1 to NJK-4 dated Nov. 6, 2015 for New Zealand Appln. No. 622666 (16 pages).
Second Affirmation of Nicola Jane Kahn with Exhibits NJK-5 to NJK-7 dated Nov. 13, 2015 for New Zealand Appln. No. 622666 (7 pages).
Third Statutory Declaration of Alastair Edwin McAuley dated Nov. 16, 2015 for New Zealand Appln. No. 622666 (28 pages).
Third Amended Notice of Opposition to Grant of Patent (marked up and clean) filed Nov. 16, 2015 in New Zealand Appln. No. 622670 (18 pages).
Second Amended Statement of Case (marked up and clean) filed Nov. 16, 2015 in New Zealand Appln. No. 622670 (34 pages).
Affirmation of Nicola Jane Kahn with Exhibits NJK-1 to NJK-4 dated Nov. 6, 2015 for New Zealand Appln. No. 622670 (16 pages).
Second Affirmation of Nicola Jane Kahn with Exhibits NJK-5 to NJK-7 dated Nov. 13, 2015 for New Zealand Appln. No. 622670 (7 pages).
Fourth Statutory Declaration of Alastair Edwin McAuley with Exhibit AM-3 dated Nov. 16, 2015 for New Zealand Appln. No. 622670 (15 pages).
Proceeding Correspondence Mailed Jan. 8, 2016 in New Zealand Application No. 701136 (2 pages).
Extension of Time Granted Mailed Jan. 7, 2016 in New Zealand Application No. 701183 (2 pages).
First Amended Notice of Opposition to Grant of Patent (marked up and clean) filed Dec. 21, 2015 and filed in New Zealand Application No. 701136 (16 pages).
First Amended Statement of Case (marked up and clean) filed Dec. 21, 2015 and filed in New Zealand Application No. 701136 (28 pages).
Affirmation of Nicola Jane Kahn with Exhibits NJK-1 to NJK-22 dated Dec. 14, 2015 filed in New Zealand Appln. Nos. 701136 and 701183 (51 pages).
Statutory Declaration of David Maurice Rapoport with Exhibit DMR-1 dated Dec. 15, 2015 filed in New Zealand Appln. Nos. 701136 and 701183 (47 pages).
Statutory Declaration of Troy Alan Baker with Exhibit TAB-1 dated Dec. 22, 2015 filed in New Zealand Appln. Nos. 701136 and 701183 (38 pages).
Second Statutory Declaration of Alastair Edwin McAuley with Exhibits AM-3 to AM-5 dated Dec. 17, 2015 (103 pages).
Extension of Time Granted mailed Mar. 9, 2016 in NZ Application No. 701136 (2 pages).
Statutory Declaration of Michael George Richardson dated Feb. 18, 2016 filed in New Zealand Appln. No. 701136 (11 pages).
Statutory Declaration of Gregory James Olsen dated Feb. 26, 2016 filed in New Zealand Appln. Nos. 701136 and 701183 (7 pages).
Statutory Declaration of Arthur Lucian Howden Roberts dated Feb. 26, 2016 filed in New Zealand Appln. Nos. 701136 and 701183 (44 pages).
Affirmation of Nicola Jane Kahn dated Feb. 26, 2016 filed in New Zealand Appln No. 701136 (15 pages).
Evidence Correspondence dated Mar. 15, 2016 in New Zealand Application No. 701136 (3 pages).
Second Amended Notice of Opposition dated Mar. 14, 2016 in New Zealand Application No. 701136 (tracked and clean) (19 pages).
Second Amended Statement of Case dated Mar. 14, 2016 in New Zealand Application No. 701136 (tracked and clean) (36 pages).
Fourth Statutory Declaration of Alastair Edwin McAuley dated Mar. 11, 2016 in New Zealand Application No. 701136 (94 pages).
Communication issued in related European Application No. 14 182 823.6 dated Nov. 27, 2015 (5 pages).
Second Statutory Declaration of Arthur Lucian Howden Roberts dated Mar. 10, 2016 in New Zealand Application Nos. 701136 and NZ 701183 (11 pages).
Second Statutory Declaration of Christopher Bryn Sparks dated Mar. 1, 2016 in New Zealand Application Nos. 701136 and NZ 701183 (1 page).
Second Statutory Declaration of Gregory James Olsen dated Mar. 4, 2016 in New Zealand Application Nos. 701136 and NZ 701183 (7 pages).
Opponent's Evidence dated Mar. 14, 2016 for New Zealand Appln No. 701136 (1 page).
Alastair Edwin McAuley Exhibit Note 6, referred to in the Fourth Statutory Declaration of Alastair Edwin McAuley dated Mar. 11, 2016 filed in New Zealand Appln No. 701136 (16 pages).
Alastair Edwin McAuley Exhibit Note 7, referred to in the Fourth Statutory Declaration of Alastair Edwin McAuley dated Mar. 11, 2016 filed in New Zealand Appln No. 701136 (18 pages).
Alastair Edwin McAuley Exhibit Note 8, referred to in the Second Statutory Declaration of Alastair Edwin McAuley dated Mar. 11, 2016 filed in New Zealand Appln No. 701136 (26 pages).
Statutory Declaration of Gregory James Olsen dated Mar. 4, 2016 in New Zealand Appln Nos. 701136 and 701183 (7 pages).
Application for Extension of Time to Mar. 29, 2016 in NZ Application No. 701136 (2 pages).
Fifth Statutory Declaration of Alastair Edwin McAuley dated Mar. 22, 2016 in New Zealand Application No. 701136 (1 page).
Extension of Time Granted dated Apr. 13, 2016 and Application for Extension of Time dated Apr. 12, 2016 in New Zealand Application No. 701183 (4 pages).
Second Affirmation of Nicola Jane Kahn dated Apr. 12, 2016 in New Zealand Application No. 701183 (8 pages).
Second Statutory Declaration of Alastair Edwin McAuley dated Apr. 11, 2016 in New Zealand Application No. 701183 (148 pages).
Deadline for Applicant to File Evidence dated Apr. 27, 2016 in New Zealand Application No. 701136 (2 pages).
Amended Notice of Opposition to Grant of Patent (marked up and clean) filed Apr. 27, 2016 and filed in New Zealand Application No. 701136 (18 pages).
Amended Statement of Case (marked up and clean) filed Apr. 27, 2016 and filed in New Zealand Application No. 701136 (32 pages).
Third Affirmation of Nicola Jane Kahn filed Apr. 26, 2016 and filed in New Zealand Application No. 701136 (5 pages).
Third Statutory Declaration of Alastair Edwin McAuley filed Apr. 26, 2016 and filed in New Zealand Application No. 701136 (117 pages).
Third Statutory Declaration of Arthur Lucian Howden Edwards filed Apr. 21, 2016 and filed in New Zealand Application No. 701136 (24 pages).
Proceeding Correspondence dated Jun. 2, 2016 filed in New Zealand Application No. 701136 (1 page).
Second Amended Notice of Opposition to Grant of Patent (Section 21) in New Zealand Application No. 701136 (9 pages).
Puritan Bennett, “Breeze SleepGear User's Guide”, Nellcor Puritan Bennett Inc., www.puritanbenett.com, (2007) (16 pages).
Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00061, dated Oct. 12, 2016 (104 pages).
Affidavit of Christopher Butler, Ultra Mirage Brochure (Ultra Mirage) in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00061, dated Sep. 6, 2016 (9 pages).
Affidavit of Christopher Butler, FlexiFit Instructions (FlexiFit) in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00061, dated Sep. 6, 2016 (23 pages).
Declaration of Jason Eaton, P.E. in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00061, dated Oct. 11, 2016 (136 pages).
Malloy, Robert A., Plastic Part Design for Injection Molding: An Introduction, pp. 336-345 (Hanser Gardner Publications, Inc., 1994) (14 pages).
Declaration of Fiona Cresswell in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00061, dated Sep. 21, 2016 (29 pages).
Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00062, dated Oct. 12, 2016 (106 pages).
Affidavit of Christopher Butler, Ultra Mirage Brochure (Ultra Mirage) in Support of Petition for Interof U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00062, dated Sep. 6, 2016 (9 pages).
Affidavit of Christopher Butler, FlexiFit Instructions (FlexiFit) dated in Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00062, dated Sep. 6, 2016 (23 pages).
Declaration of Jason Eaton, P.E. in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00062, dated Oct. 11, 2016 (130 pages).
Declaration of Fiona Cresswell, in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00062, dated Sep. 21, 2016 (29 pages).
Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00064, dated Oct. 12, 2016 (102 pages).
Declaration of Jason Eaton, P.E. in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00064, dated Oct. 11, 2016 (133 pages).
Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00065, dated Oct. 12, 2016 (136 pages).
Declaration of Jason Eaton, P.E. in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00065, dated Oct. 11, 2016 (176 pages).
Affidavit of Christopher Butler, Ultra Mirage Brochure (Ultra Mirage) in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00065, dated Sep. 6, 2016 (9 pages).
Affidavit of Christopher Butler, FlexiFit Instructions (FlexiFit) dated in Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00065, dated Sep. 6, 2016 (23 pages).
Notification of the First Office Action issued in related Chinese Application No. 2015103415970 with English Translation, dated Dec. 30, 2016 (15 pages).
Notification of the First Office Action issued in related Chinese Application No. 201510341599.X with English Translation, dated Dec. 29, 2016 (7 pages).
Petition for Inter Partes Review of U.S. Pat. No. 9,027,556, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00501, dated Dec. 16, 2016 (130 pages).
Declaration of Richard Lordo, P.E. in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,027,556, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00501, dated Dec. 16, 2016 (192 pages).
Petition for Inter Partes Review of U.S. Pat. No. 9,027,556, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00504, dated Dec. 16, 2016 (133 pages).
Declaration of Richard Lordo, P.E. in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,027,556, Fisher & Resmed Limited, Case No. IPR2017-00504, dated Dec. 16, 2016 (194 pages).
Sixth Statutory Declaration of Alastair Edwin McAuley filed Nov. 2, 2016 and filed in New Zealand Application No. 701136 (9 pages).
Statutory Declaration of Daniel Anthony Hearn filed Sep. 13, 2016 and filed in New Zealand Application No. 701136 (6 pages).
Notification of the First Office Action issued in related Chinese Application No. 201510342347.9, with English Translation, dated Sep. 28, 2016 (24 pages).
Examination Report—Communication Purusant to Article 94(3) EPC issued in corresponding European Application No. 14 182 823.6-1662 dated Dec. 7, 2016, 4 pages.
Fourth Amended Notice of Opposition to Grant of Patent (Section 21) marked-up and clean formats dated Dec. 19, 2016 in New Zealand Application No. 607032 (16 pages).
Fourth Amended Notice of Opposition to Grant of Patent (Section 21) marked-up and clean formats dated Dec. 23, 2016 in New Zealand Application No. 701183 (15 pages).
Fourth Amended Notice of Opposition to Grant of Patent (Section 21) marked-up and clean formats dated Dec. 23, 2016 in New Zealand Application No. 701136 (17 pages).
Fourth Amended Notice of Opposition to Grant of Patent (Section 21) marked-up and clean formats filed Dec. 23, 2016 in New Zealand Application No. 622666 (16 pages).
Third Amended Notice of Opposition to Grant of Patent (Section 21) marked-up and clean formats filed Sep. 1, 2016 in New Zealand Application No. 701136 (18 pages).
Third Amended Statement of Case marked-up and clean formats filed Sep. 1, 2016 in New Zealand Application No. 701136 (32 pages).
Second Amended Notice of Opposition to Grant of Patent (Section 21) marked-up and clean formats filed Jan. 17, 2017 in related New Zealand Application No. 624599 (16 pages).
Third Amended Statement of Case marked-up and clean formats filed Jan. 31, 2017 in related New Zealand Application No. 607032 (45 pages).
Fifth Amended Notice of Opposition to Grant of Patent (Section 21) marked-up and clean formats filed Jan. 31, 2017 in related New Zealand Application No. 607032 (11 pages).
Fourth Amended Statement of Case marked-up and clean formats filed Jan. 31, 2017 in related New Zealand Application No. 701136 (42 pages).
Fifth Amended Notice of Opposition to Grant of Patent (Section 21) marked-up and clean formats filed Jan. 31, 2017 in related New Zealand Application No. 701136 (13 pages).
Second Amended Statement of Case marked-up and clean formats filed Jan. 31, 2017 in related New Zealand Application No. 701183 (36 pages).
Second Amended Notice of Opposition to Grant of Patent (Section 21) marked-up and clean formats filed Jan. 31, 2017 in related New Zealand Application No. 701183 (12 pages).
Decision Instituting Inter Partes Review, 37 C.F.R § 42.108, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00061, U.S. Pat. No. 9,119,931 B2, dated Mar. 23, 2017 (26 pages).
Scheduling Order, 37 C.F.R. § 42.108, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00061, U.S. Pat. No. 9,119,931 B2, dated Mar. 23, 2017 (8 pages).
Decision Instituting Inter Partes Review, 37 C.F.R § 42.108, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00062, U.S. Pat. No. 9,119,931 B2, dated Mar. 31, 2017 (37 pages).
Scheduling Order, 37 C.F.R. § 42.108, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00062, U.S. Pat. No. 9,119,931 B2, dated Mar. 31, 2017 (8 pages).
First Office Action issued in related Japanese Application No. 2016-092520 with English translation dated Mar. 27, 2017 (18 pages).
EPO Brief Communication issued in related European Application No. 13197251.5 dated Mar. 28, 2017 (10 pages).
EPO Communication of a Notice of Opposition issued in related European Application No. 13197251.5 dated Sep. 8, 2016 (56 pages).
R.A. Malloy in “Plastic part design for injection molding: An introduction”; Section 6.3 Snap joint assemblies, 1994, Munich, Hanser.
Statutory Declaration of Christopher Bryn Sparks in related New Zealand Application Nos. 701136, 701183, 607032, 622666, and 622670, dated Apr. 19, 2017 (6 pages).
Statutory Declaration of Alastair Edwin McAuley in Relation to Simplicity Mask and Sleepnet IQ Mask in related New Zealand Application Nos. 622666, 622670, 607032, 701136, 701183, and 624599, dated Apr. 21, 2017 (5 pages).
Statutory Declaration of Arthur Lucian Howden Roberts in related New Zealand Application Nos. 607032, 622666, 622670, and 624599, dated Apr. 12, 2017 (11 pages).
Statutory Declaration of Daniel Anthony Hearn in related New Zealand Application Nos. 607032, 622666, 622670, 701136 and 701136, dated Jan. 27, 2017 (41 pages).
Fifth Statutory Declaration of Alastair Edwin McAuley in related New Zealand Application No. 607032, dated Apr. 21, 2017 (153 pages).
EXH-AM4 to AM-23 referred to in Fifth Statutory Declaration of Alastair Edwin McAuley in related New Zealand Application No. 607032, dated Apr. 21, 2017 (188 pages).
Fourth Statutory Declaration of Alastair Edwin McAuley in related New Zealand Application No. 622666, dated Apr. 21, 2017 (220 pages).
EXH-AM3 to AM24 referred to in Fourth Statutory Declaration of Alastair Edwin McAuley in related New Zealand Application No. 622666, dated Apr. 21, 2017 (191 pages).
Fifth Statutory Declaration of Alastair Edwin McAuley in related New Zealand Application No. 607032, dated Apr. 21, 2017 (238 pages).
EXH-AM4 to AM26 referred to in Fifth Statutory Declaration of Alastair Edwin McAuley in related New Zealand Application No. 622670, dated Apr. 21, 2017 (193 pages).
First Examination Report issued in related Australian Application No. 2016222397, dated Feb. 24, 2017, 9 pages.
Decision Denying Institution of Inter Partes Review, 37 C.F.R. § 42.108, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00064, U.S. Pat. No. 9,119,931 B2, dated Apr. 11, 2017 (25 pages).
Decision Denying Institution of Inter Partes Review, 37 C.F.R. § 42.108, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00065, U.S. Pat. No. 9,119,931 B2, dated Apr. 11, 2017 (15 pages).
Notification of Second Office Action issued in related Chinese Application No. 201510342347.9 with English translation dated Apr. 12, 2017 (16 pages).
Third Amended Statement of Case marked-up and clean formats filed Jan. 31, 2017 in related New Zealand Application No. 622670 (47 pages).
Declaration of Jason Eaton, P.E., In Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Case No. IPR2017-01658, executed Jun. 22, 2017 (352 pages).
Complaint of ResMed Ltd, ResMed Inc., and ResMed Corp. Under Section 337 of the Tariff Act of 1930, as amended, Investigation No. 337-TA-1022, executed Aug. 17, 2016 (30 pages).
Answer of ResMed Corp. to Complaint for Patent Infringement and Counterclaims, Fisher &Paykel Healthcare Ltd. v. ResMed Corp., Case No. 3:16-cv-02068-DMS-WVG (S.D. Cal.), filed Sep. 7, 2016 (94 pages).
Declaration of Fiona Cresswell, in Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Case No. IPR2017-01658, executed Sep. 21, 2016 (5 pages).
Declaration of Jason Eaton, P.E., In Support of Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, Case No. IPR2017-01659, executed Jun. 22, 2017 (333 pages).
Excerpts From the File History of U.S. Pat. No. 9,119,931, D'Souza et al., entitled: Mask System, filed in IPR2017-01658 and IPR2017-01659 on Jun. 22, 2017 (485 pages).
Excerpt from Webster's II New College Dictionary, Third Edition, Houghton Mifflin Company, definition for the term “accommodate”, 2005, (3 pages).
Excerpt from The Oxford American College Dictionary, Oxford University Press, Inc., definition for the term “accommodate”, 2002, (3 pages).
Second Amended Statement of Case marked-up and clean formats filed May 29, 2017 in related New Zealand Application No. 624599 (80 pages).
Third Amended Notice of Opposition to Grant of Patent (Section 21) marked-up and clean formats filed May 29, 2017 in related New Zealand Application No. 624599 (15 pages).
Second Statutory Declaration of Christopher Bryn Sparks in related New Zealand Application Nos. 701136, 701183, 607032, 622666, and 622670, dated Apr. 19, 2017 (6 pages).
Fourth Statutory Declaration of Alastair Edwin McAuley in related New Zealand Application No. 701183, dated May 31, 2017 (306 pages).
Statutory Declaration of Daniel Anthony Hearn in related New Zealand Application Nos. 607032, 622666, 622670, and 701136, dated Jan. 27, 2017 (41 pages).
Seventh Statutory Declaration of Alastair Edwin McAuley in related New Zealand Application No. 701136, dated May 31, 2017 (332 pages).
Scheduling Order, 37 C.F.R. § 42.5, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00501, U.S. Pat. No. 9,027,556 B2, dated Jun. 14, 2017 (10 pages).
Decision, 37 C.F.R. § 42.5, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00501, U.S. Pat. No. 9,027,556 B2, dated Jun. 14, 2017 (44 pages).
Scheduling Order, 37 C.F.R. § 42.5, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00504, U.S. Pat. No. 9,027,556 B2, dated Jun. 14, 2017 (10 pages).
Decision, 37 C.F.R. § 42.5, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-00504, U.S. Pat. No. 9,027,556 B2, dated Jun. 14, 2017 (51 pages).
Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, 37 C.F.R. § 42.5, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-01658, dated Jun. 22, 2017, (131 pages).
Petition for Inter Partes Review of U.S. Pat. No. 9,119,931, 37 C.F.R. § 42.5, Fisher & Paykel Healthcare v. Resmed Limited, Case No. IPR2017-01659, dated Jun. 22, 2017, (125 pages).
Office Action issued in related European Application No. 09 71 6457.8, dated Jun. 19, 2017, (8 pages).
Non-Final Office Action issued in related U.S. Appl. No. 13/964,280, dated May 16, 2017 (77 pages).
Fifth Statutory Declaration of Alastair Edwin McAuley dated Nov. 15, 2017 and filed in related New Zealand Application No. 622666 with Exhibits AM-25 to AM-37 (352 pages).
Statutory Declaration of Jessica Michele Vranjes dated Nov. 10, 2017 and filed in New Zealand Application Nos. 622666, 622670, 607032, 624599, 612787, 701136 and 701183, with Exhibit JV-1 (8 pages).
Brief Communication dated Dec. 6, 2017 in EP Patent No. 20708258 (1 page), including Response filed by Opponent Fisher & Paykel Healthcare Limited on Dec. 1, 2017 (42 pages), with Additional Document D12 (Judgment of the UK High Court of Justice regarding the UK part of the opposed patent dated Nov. 10, 2017) (54 pages), Additional Document D13 (Decision of the Regional Court of Munich regarding the DE part of the opposed patent dated Sep. 21, 2017) (14 pages), Additional Document D14 (U. Delpy et al., “Schnappverbindungen aus Kunststoff”, expertverlag, 1989) (16 pages), Additional Document D15 (Affidavit by Mr Jason Eaton) (6 pages) and Additional Document D16 (Overview table regarding the auxiliary requests filed by the patentee) (2 pages); (135 total pages).
Second Statutory Declaration of Daniel Anthony Hearn signed Oct. 27, 2017 and filed in New Zealand Application Nos. NZ 607032, NZ 622666, and NZ 622670, including Exhibits DH-20 and DH-21 (4 pages).
Statutory Declaration of Jonathan Ellis signed Oct. 27, 2017 and filed in New Zealand Application Nos. NZ 622666, NZ 622670, NZ 607032, NZ 624599, NZ 612787, NZ 701136, and NZ 701183, including Exhibits JE-1 to JE-5 (30 pages).
Statutory Declaration of Brigitte Michelle Jeffs signed Oct. 27, 2017 and filed in New Zealand Application Nos. NZ 622666, NZ 622670, NZ 607032, NZ 624599, NZ 612787, NZ 701136, and NZ 701183 (2 pages).
Sixth Statutory Declaration of Alastair Edwin McAuley signed Oct. 30, 2017 and filed in New Zealand Application No. NZ 607032, including Exhibits AM-24 to AM-31 (333 pages).
Ng et al., U.S. Appl. No. 17/361,420, filed Jun. 29, 2021, for “Mask System With Snap-Fit Shroud,” (parent application).
Second Office Action issued in related Chinese Application No. 201510341599 dated Aug. 28, 2017, with English translation (21 pages).
Second Office Action issued in related Chinese Application No. 201510341597.0 dated Sep. 11, 2017, with English translation (12 pages).
Fisher & Paykel Healthcare's Reply to ResMed Limited's Patent Owner Response in U.S. Pat. No. 9,119,931, filed in IPR2017-00061 on Sep. 25, 2017 (37 pages).
Transcript of the Deposition of Geoffrey Sleeper taken on Aug. 24, 2017, Ex. 1025, (278 pages).
Non-Final Official Action issued in related U.S. Appl. No. 15/682,117 dated Dec. 18, 2017, 157 pages.
Notification of Third Office Action issued in related Chinese Application No. 201510342347.9 dated Dec. 25, 2017, with English translation, 9 pages.
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 9,119,931 B2, Case No. IPR2017-01658, dated Jan. 16, 2018 (17 pages).
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 9,119,931 B2, Case No. IPR2017-01659, dated Jan. 16, 2018 (17 pages).
Notification of the Third Office Action dated Jan. 17, 2018 in Chinese Application No. 201510341599.X, with English Translation (11 pages).
Statutory Declaration of Yung Chee Kenneth Chong dated Jan. 30, 2018 in connection with New Zealand Application No. 701136, including Exhibit KC-1 (47 pages).
Statutory Declaration of Daniel Anthony Hearn dated Jan. 27, 2017 in connection with New Zealand Application Nos. NZ 607032, NZ 622666, NZ 622670 and NZ 701136, including Exhibits DH-1 to DH-19 (41 pages).
Eighth Statutory Declaration of Alastair Edwin McAuley dated Jan. 30, 2018 in connection with New Zealand Application No. 701136, including Exhibits AM-23 to AM-34 (362 pages).
Letter filed by AJ Park on behalf of Fisher & Paykel Healthcare Limited in New Zealand Application Nos. 701136 and 701183 on Feb. 28, 2018 (2 pages).
Ninth Statutory Declaration of Alastair Edwin McAuley dated Feb. 28, 2018 and filed in New Zealand Application No. 701136, (10 pages).
Fifth Statutory Declaration of Alastair Edwin McAuley dated Feb. 28, 2018 and filed in New Zealand Application No. 701183, (325 pages).
Sixth Statutory Declaration of Alastair Edwin McAuley dated Feb. 28, 2018 and filed in New Zealand Application No. 701183, (4 pages).
Decision of Rejection issued in related Japanese Application No. 2016-92520 dated Feb. 5, 2018, with English Translation, (7 pages).
Final Written Decision of U.S. Pat. No. 9,119,931 B2, Case No. IPR2017-00061, dated Mar. 21, 2018 (50 pages).
Final Written Decision of U.S. Pat. No. 9,119,931 B2, Case No. IPR2017-00062, dated Mar. 29, 2018 (58 pages).
Office Action dated Sep. 9, 2022 issued in Chinese Application No. 201910247029.2 with English translation (20 pages).
Final Rejection dated Jan. 4, 2023 in Japanese Application No. 2021-132742, with English translation, 7 pages.
Related Publications (1)
Number Date Country
20230046684 A1 Feb 2023 US
Provisional Applications (3)
Number Date Country
61136617 Sep 2008 US
61074893 Jun 2008 US
61064406 Mar 2008 US
Continuations (10)
Number Date Country
Parent 17847344 Jun 2022 US
Child 17979614 US
Parent 17474357 Sep 2021 US
Child 17847344 US
Parent 17361420 Jun 2021 US
Child 17474357 US
Parent 15964887 Apr 2018 US
Child 17361420 US
Parent 15724732 Oct 2017 US
Child 15964887 US
Parent 15682117 Aug 2017 US
Child 15724732 US
Parent 15440972 Feb 2017 US
Child 15682117 US
Parent 13964280 Aug 2013 US
Child 15440972 US
Parent 13745077 Jan 2013 US
Child 13964280 US
Parent 12736024 US
Child 13745077 US